<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="review-article" dtd-version="1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CEP</journal-id>
<journal-title-group>
<journal-title>Clinical and Experimental Pediatrics</journal-title><abbrev-journal-title>Clin Exp Pediatr</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2713-4148</issn>
<publisher>
<publisher-name>Korean Pediatric Society</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3345/cep.2022.00150</article-id>
<article-id pub-id-type="publisher-id">cep-2022-00150</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
<subj-group subj-group-type="heading">
<subject>Cardiology</subject>
</subj-group></subj-group></article-categories>
<title-group>
<article-title>Research trends on causes of Kawasaki disease in the COVID-19 era: focus on viral infections</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8377-5802</contrib-id>
<name><surname>Lee</surname><given-names>Young Hwan</given-names></name>
<degrees>MD</degrees>
<xref ref-type="corresp" rid="c1-cep-2022-00150"/>
<xref ref-type="aff" rid="af1-cep-2022-00150"></xref>
</contrib>
<aff id="af1-cep-2022-00150">
Department of Pediatrics, Yeungnam University College of Medicine, Daegu, <country>Korea</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-cep-2022-00150">Corresponding author: Young Hwan Lee, MD. Department of Pediatrics, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea Email: <email>yhlee3535@ynu.ac.kr</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>1</month>
<year>2023</year></pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>6</month>
<year>2022</year></pub-date>
<volume>66</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>11</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>01</month>
<year>2022</year></date>
<date date-type="rev-recd">
<day>12</day>
<month>05</month>
<year>2022</year></date>
<date date-type="accepted">
<day>14</day>
<month>05</month>
<year>2022</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x000a9; 2023 by The Korean Pediatric Society</copyright-statement>
<copyright-year>2023</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<abstract><p>Despite studies on the etiology of Kawasaki disease (KD) ongoing for half a century since its discovery, its cause has not yet been clearly identified. Although the clinical, epidemiological, and pathophysiological characteristics of KD are presumed to be closely related to infectious diseases, studies of various pathogens to identify its etiology have been actively conducted. To date, bacteria, fungi, and viruses have been investigated to determine the relationship between KD and infection, among which viruses have attracted the most attention. In particular, during the coronavirus disease 2019 pandemic, there were many reports in Europe of a sharp increase in cases of Kawasaki-like disease (KLD), while conflicting reports that the prevalence of KD decreased due to thorough &#x0201c;social distancing&#x0201d; or &#x0201c;wearing mask&#x0201d; in Asian countries drew more attention regarding the association between KD and viral infection. Therefore, the differential diagnosis of KD from KLD with these similar spectra has become a very important issue; simultaneously, research to solve questions about the association between KD and viral infections, including sudden acute respiratory syndrome coronavirus 2, is drawing attention again. Moreover, a new concept has emerged that immune responses occurring in patients with KD can be caused by the pathogen itself as well as host cells damaged by infection. This paper summarizes the research trends into KD etiology and related pathophysiology, especially its association with viral infections, and present future research tasks to increase our understanding of KD.</p></abstract>
<kwd-group>
<kwd>Kawasaki disease</kwd>
<kwd>Viral infection</kwd>
<kwd>Viruses</kwd>
<kwd>Etiology</kwd>
</kwd-group>
</article-meta>
<notes>
<title>Key message</title>
<boxed-text>
<p>&#x02219; The etiology of Kawasaki disease (KD) is unclear, but its clinical, epidemiological, and pathophysiological characteristics are strongly associated with infectious diseases.</p>
<p>&#x02219; In the coronavirus disease 2019 pandemic era, viruses are attracting the most attention. Sudden acute respiratory syndrome coronavirus 2 infection causes various hyperinflammation in children that require differentiation from KD.</p>
<p>&#x02219; Immune responses in patients with KD may be induced by host cell damage. To effectively prevent and treat KD, the genetic background and immune responses of KD patients and triggering pathogens require identification.</p>
</boxed-text>
</notes></front>
<body>
<p><xref rid="f1-cep-2022-00150" ref-type="fig"/></p>
<p><bold>Graphical abstract.</bold>Summary of paradigm for pathophysiological research in Kawasaki disease. KD, Kawasaki disease; COVID-19, coronavirus disease 2019; DDx., differential diagnosis; MIS-C, multisystem inflammatory syndrome in children.</p>
<sec sec-type="intro">
<title>Introduction</title>
<p>Although the coronavirus disease 2019 (COVID-19) pandemic has hampered daily life, it has shed new light on many aspects. The emergence of new diseases always intimidates people but occasionally aids the development of a new approach to the study of diseases that have remained unsolved.</p>
<p>Kawasaki disease (KD) is an acute systemic vasculitis that mainly manifests in children aged &lt;5 years whose diagnosis usually depends on its clinical manifestations. KD is related to the patient&#x00027;s genetic sensitivity and risk of infection &#x0005b;<xref ref-type="bibr" rid="b1-cep-2022-00150">1</xref>&#x0005d;, and although various studies have examined its etiology for more than half a century since its introduction by Tomisaku Kawasaki in 1967 &#x0005b;<xref ref-type="bibr" rid="b2-cep-2022-00150">2</xref>&#x0005d;, it has yet to be clarified.</p>
<p>Kawasaki-like disease (KLD), also known as multisystem inflammatory syndrome in children (MIS-C), was reported for the first time in Europe last year &#x0005b;<xref ref-type="bibr" rid="b3-cep-2022-00150">3</xref>&#x0005d; in pediatric patients with COVID-19. Although MIS-C shares some clinical features with KD, the 2 conditions are distinct. However, the reemergence of MIC-C reminded us of the apparent but unconfirmed association between KD and COVID-19 infection and raised expectations about KD pathology finally being resolved &#x0005b;<xref ref-type="bibr" rid="b4-cep-2022-00150">4</xref>-<xref ref-type="bibr" rid="b6-cep-2022-00150">6</xref>&#x0005d;.</p>
<p>Recent reports &#x0005b;<xref ref-type="bibr" rid="b7-cep-2022-00150">7</xref>-<xref ref-type="bibr" rid="b9-cep-2022-00150">9</xref>&#x0005d; showed that the incidence of KD significantly decreased versus that in the same period during the COVID-19 pandemic, when mask wearing and social distancing were implemented in Asian countries, where the KD prevalence was high. In contrast, the number of KLD cases has significantly increased in the United States &#x0005b;<xref ref-type="bibr" rid="b10-cep-2022-00150">10</xref>&#x0005d;, Italy &#x0005b;<xref ref-type="bibr" rid="b11-cep-2022-00150">11</xref>&#x0005d;, and the United Kingdom &#x0005b;<xref ref-type="bibr" rid="b12-cep-2022-00150">12</xref>&#x0005d;, where COVID-19 was more prevalent. These conflicting phenomena raised the expectation that the association between KD and viral infections could be confirmed. Therefore, this study briefly summarizes the trends and results of research on the possible association between KD and infectious diseases, especially viral infections.</p>
</sec>
<sec>
<title>Research on cause of KD</title>
<p>In previous studies, KD was not controversial because abnormal immune responses in individuals with certain genetic backgrounds after infection are important mechanisms &#x0005b;<xref ref-type="bibr" rid="b1-cep-2022-00150">1</xref>&#x0005d;. Although KD is considered highly associated with infectious diseases in clinical, epidemiological, and pathophysiological aspects, its pathology is among the most notable research topics.</p>
<p><xref rid="t1-cep-2022-00150" ref-type="table">Table 1</xref> summarizes the evidence suggesting a connection between KD and infection. First, most clinical symptoms included in the diagnostic criteria for KD (such as acute fever, skin rash, conjunctival injection, redness of the oral mucosa including strawberry tongue, and lymphadenitis) as well as accompanying respiratory symptoms are similar to those of acute infectious diseases. Epidemiologically, it is common in young children aged &lt;5 years who are vulnerable to infections, and considering its occurrence in siblings of affected children &#x0005b;<xref ref-type="bibr" rid="b13-cep-2022-00150">13</xref>,<xref ref-type="bibr" rid="b14-cep-2022-00150">14</xref>&#x0005d;, the high prevalence rate in countries in Northeast Asia &#x0005b;<xref ref-type="bibr" rid="b15-cep-2022-00150">15</xref>&#x0005d;, and the marked seasonal variations &#x0005b;<xref ref-type="bibr" rid="b16-cep-2022-00150">16</xref>&#x0005d;, it is believed to be an infectious disease characterized by epidemics. Recently, studies using big data and time series analysis of disease statistics have reported that various viral infection outbreaks precede KD &#x0005b;<xref ref-type="bibr" rid="b17-cep-2022-00150">17</xref>,<xref ref-type="bibr" rid="b18-cep-2022-00150">18</xref>&#x0005d;. Moreover, pathophysiologically, the pattern of explosive systemic vasculitis in the acute phase is associated with microbial toxins or superantigens, and the fact that systemic vasculitis is sometimes self-limiting is similar to viral infectious diseases. Immunologically, the initial neutrophilic predominance in peripheral blood and arterial tissues in KD is compatible with an innate immune response to acute infection &#x0005b;<xref ref-type="bibr" rid="b19-cep-2022-00150">19</xref>&#x0005d;.</p>
</sec>
<sec>
<title>Research on KD-associated infectious pathogens</title>
<p>Although the exact cause of KD remains unknown, studies are underway. To identify the pathogen that causes a certain disease, some conditions must be met. According to Nagata &#x0005b;<xref ref-type="bibr" rid="b1-cep-2022-00150">1</xref>&#x0005d;, if an infectious pathogen has the potential to induce KD, it should (1) frequently be detected in KD patients, (2) be associated not only with clinical symptoms of KD disease, (3) have a coronary artery lesion induction mechanism, and (4) have an epidemiological association.</p>
<p>Nagata &#x0005b;<xref ref-type="bibr" rid="b1-cep-2022-00150">1</xref>&#x0005d; recently categorized 4 main theories about KD etiology: (1) direct infectious vasculitis, (2) autoantigen, (3) superantigen, and (4) RNA virus. However, none of these studies have been able to justify this epidemic.</p>
<p>To date, a wide variety of bacteria &#x0005b;<xref ref-type="bibr" rid="b20-cep-2022-00150">20</xref>-<xref ref-type="bibr" rid="b29-cep-2022-00150">29</xref>&#x0005d; and viruses &#x0005b;<xref ref-type="bibr" rid="b30-cep-2022-00150">30</xref>-<xref ref-type="bibr" rid="b50-cep-2022-00150">50</xref>&#x0005d; as well as the occasional fungus &#x0005b;<xref ref-type="bibr" rid="b51-cep-2022-00150">51</xref>,<xref ref-type="bibr" rid="b52-cep-2022-00150">52</xref>&#x0005d; have been reported as KD-associated infectious pathogens (<xref rid="t2-cep-2022-00150" ref-type="table">Table 2</xref>). Studies of most KD-associated pathogens are based on the theory that these pathogens act as antigens or even superantigens in genetically sensitive individuals that result in inappropriate immune responses rather than directly infecting individuals.</p>
<p>First, <italic>Staphylococcus</italic> and <italic>Streptococcus</italic> species are at the center of the superantigen theory, which has attracted attention related to KD pathogenesis. Leung et al. &#x0005b;<xref ref-type="bibr" rid="b20-cep-2022-00150">20</xref>&#x0005d; confirmed that the selective expansion of V&#x003b2;2&#x0002b; T cells in most KD patients may be caused by <italic>Staphylococcus</italic> and <italic>Streptococcus</italic> species. Matsubara and Fukaya &#x0005b;<xref ref-type="bibr" rid="b22-cep-2022-00150">22</xref>&#x0005d; provided the following evidence of <italic>Staphylococcus</italic> and <italic>Streptococcus</italic> superantigens in the KD pathogenesis: the skewed distribution of the V&#x003b2; repertoire, superantigen-producing bacteria isolated from KD patients, serological responses to superantigens produced by <italic>Staphylococcus aureus</italic>, and Group A <italic>Streptococcus</italic> from case-control studies. Animal models have demonstrated the hallmarks of a superantigen-mediated response. In addition, <italic>Yersinia pseudotuberculosis</italic> &#x0005b;<xref ref-type="bibr" rid="b24-cep-2022-00150">24</xref>&#x0005d;, <italic>Pseudomonas aeruginosa</italic>&#x0005b; <xref ref-type="bibr" rid="b26-cep-2022-00150">26</xref>&#x0005d;, <italic>Chlamydia pneumoniae</italic> &#x0005b;<xref ref-type="bibr" rid="b27-cep-2022-00150">27</xref>&#x0005d;, and <italic>Mycoplasma pneumoniae</italic> &#x0005b;<xref ref-type="bibr" rid="b28-cep-2022-00150">28</xref>&#x0005d; are suspected causative bacteria, but this remains unconfirmed due to other opinions (<xref rid="t3-cep-2022-00150" ref-type="table">Table 3</xref>).</p>
<p>Wang et al. &#x0005b;<xref ref-type="bibr" rid="b49-cep-2022-00150">49</xref>&#x0005d; summarized that various common pathogens, mainly bacterial toxins and viral antigens, act as external superantigens in susceptible hosts, causing several diseases such as KD, toxic shock syndrome, and rheumatoid arthritis. In a study of previous or concurrent infections in patients with KD, Fern&#x000e1;ndez-Cooke et al. &#x0005b;<xref ref-type="bibr" rid="b50-cep-2022-00150">50</xref>&#x0005d; reported that 17.2% of patients had recent previous infections within the last 4 weeks, while 16.3% had microbiologically confirmed infections in the acute phase. They also emphasized that a standard protocol for microbial testing should be prepared to identify actual infections in patients with KD.</p>
<p>Examples of studies that estimate fungi as the cause of KD include the development of KD-like animal models by Takahashi et al. &#x0005b;<xref ref-type="bibr" rid="b53-cep-2022-00150">53</xref>&#x0005d; that induced vasculitis in mice with <italic>Candida albicans</italic> extracts and that by Rod&#x000f3; et al. &#x0005b;<xref ref-type="bibr" rid="b54-cep-2022-00150">54</xref>&#x0005d; that studied the relationship between KD and <italic>Candida</italic> species. Rod&#x000f3; et al. &#x0005b;<xref ref-type="bibr" rid="b54-cep-2022-00150">54</xref>&#x0005d; explained the seasonal cluster phenomenon of KD as the possibility of aerosol transmission by <italic>Candida</italic> species via tropospheric winds.</p>
<p>These numerous reports imply that various pathogens are a potential cause of KD. Nevertheless, conclusive evidence that infections by these individual pathogens cause KD is lacking, and the possibility of concurrent infections has not been completely excluded &#x0005b;<xref ref-type="bibr" rid="b53-cep-2022-00150">53</xref>&#x0005d;.</p>
</sec>
<sec>
<title>Studies of association of KD and viral infection</title>
<p>In the theory of KD caused by infectious pathogens, bacteria were mainly mentioned first, but interest has gradually shifted toward viruses. The association between viruses and KD has been steadily attracting attention &#x0005b;<xref ref-type="bibr" rid="b30-cep-2022-00150">30</xref>-<xref ref-type="bibr" rid="b51-cep-2022-00150">51</xref>,<xref ref-type="bibr" rid="b55-cep-2022-00150">55</xref>-<xref ref-type="bibr" rid="b60-cep-2022-00150">60</xref>&#x0005d;. Speculation that a viral infection could be a KD etiology was triggered by the occurrence of seasonal outbreaks reported in Japan in 1979, 1982, and 1986 &#x0005b;<xref ref-type="bibr" rid="b61-cep-2022-00150">61</xref>&#x0005d;.</p>
<p>In the case of KD accompanied by viral infection, the virus is suspected to be the etiology as follows: Epstein-Barr virus (EBV) &#x0005b;<xref ref-type="bibr" rid="b31-cep-2022-00150">31</xref>,<xref ref-type="bibr" rid="b32-cep-2022-00150">32</xref>&#x0005d;, parvovirus &#x0005b;<xref ref-type="bibr" rid="b33-cep-2022-00150">33</xref>&#x0005d;, dengue virus &#x0005b;<xref ref-type="bibr" rid="b38-cep-2022-00150">38</xref>&#x0005d;, varicella-zoster virus &#x0005b;<xref ref-type="bibr" rid="b39-cep-2022-00150">39</xref>&#x0005d;, human immunodeficiency virus &#x0005b;<xref ref-type="bibr" rid="b40-cep-2022-00150">40</xref>&#x0005d;, human bocavirus &#x0005b;<xref ref-type="bibr" rid="b42-cep-2022-00150">42</xref>&#x0005d;, human adenovirus &#x0005b;<xref ref-type="bibr" rid="b43-cep-2022-00150">43</xref>&#x0005d;, human coronavirus OC43/HKU1 &#x0005b;<xref ref-type="bibr" rid="b43-cep-2022-00150">43</xref>&#x0005d;, parainfluenza virus type 3 &#x0005b;<xref ref-type="bibr" rid="b43-cep-2022-00150">43</xref>&#x0005d;, torque teno virus 7 &#x0005b;<xref ref-type="bibr" rid="b44-cep-2022-00150">44</xref>&#x0005d;, and influenza A &#x0005b;<xref ref-type="bibr" rid="b45-cep-2022-00150">45</xref>&#x0005d;. These reports are cases in which an infection with a related pathogen was confirmed in various samples extracted from patients treated for KD, but the possibility of accidental coinfections cannot be ruled out regardless of KD status. In case-control studies of viruses as the etiology of KD, adenovirus, human herpesvirus 6, rotavirus, and human coronavirus (HCoV) were reported. Okano et al. &#x0005b;<xref ref-type="bibr" rid="b30-cep-2022-00150">30</xref>&#x0005d; reported that patients with KD with 2 outbreaks in 1982 and 1985 had a significantly higher positive rate of adenovirus antibodies than the control group. Meanwhile, Song et al. &#x0005b;<xref ref-type="bibr" rid="b44-cep-2022-00150">44</xref>&#x0005d; emphasized that if adenovirus is detected incidentally in KD, it is necessary to carefully distinguish it from acute adenovirus infection itself. This is because human adenovirus is accompanied by long-term fever, skin rash, and increased inflammatory markers in children that can cause clinical characteristics very similar to those of KD. Okano et al. &#x0005b;<xref ref-type="bibr" rid="b34-cep-2022-00150">34</xref>&#x0005d; reported that the human herpesvirus 6 antibody positivity rate was higher in 22 patients with KD than in 16 age-and sex-matched healthy controls. Matsuno et al. &#x0005b;<xref ref-type="bibr" rid="b36-cep-2022-00150">36</xref>&#x0005d; reported that the positive rate of rotavirus antibodies was significantly higher in 75 KD patients and 39 age-matched controls. Shirato et al. &#x0005b;<xref ref-type="bibr" rid="b41-cep-2022-00150">41</xref>&#x0005d; reported that HCoV-229E was more likely involved in the development of KD than HCoV-NL63 using immunofluorescence assays and virus neutralization tests. However, Choe et al. &#x0005b;<xref ref-type="bibr" rid="b47-cep-2022-00150">47</xref>&#x0005d; analyzed nationally representative data from 2016&#x02013;2019 in Korea and reported that seasonal variations in the frequencies of HCoV were not significantly associated with the incidence of KD. Quiat et al. &#x0005b;<xref ref-type="bibr" rid="b51-cep-2022-00150">51</xref>&#x0005d; reported no serological evidence that KD patients were exposed to 58 known viruses compared to controls in the acute and subacute stages of KD.</p>
<p>Epidemiologically, although some differences exist among countries, Uehara and Belay &#x0005b;<xref ref-type="bibr" rid="b57-cep-2022-00150">57</xref>&#x0005d; reported that KD occurs in clusters and community-wide outbreaks with distinct seasonality, indicating that KD can be caused by infectious agents such as viruses or agents that remain elusive. Similar results were reported of epidemiological investigations of big data by Korean researchers &#x0005b;<xref ref-type="bibr" rid="b17-cep-2022-00150">17</xref>,<xref ref-type="bibr" rid="b18-cep-2022-00150">18</xref>&#x0005d;, suggesting that respiratory viruses may be causative pathogens that trigger KD among viral infections. Lim et al. &#x0005b;<xref ref-type="bibr" rid="b17-cep-2022-00150">17</xref>&#x0005d; reported that several viruses, including human respiratory syncytial virus, rotavirus, norovirus, and human rhinovirus, precede KD by 1&#x02013;2 months in the same cycle as the trend of KD diagnosis in a study of big data in Korea, supporting the possibility that the virus is the major cause of KD. Kang et al. &#x0005b;<xref ref-type="bibr" rid="b18-cep-2022-00150">18</xref>&#x0005d; reported a cohort study of a time series analysis of children and youth in South Korea with KD, stating that respiratory infections caused by rhinovirus and respiratory syncytial virus as well as varicella outbreaks were significantly correlated with KD at 1&#x02013;3 months before KD outbreaks. Aguirre et al. &#x0005b;<xref ref-type="bibr" rid="b52-cep-2022-00150">52</xref>&#x0005d; reported a direct temporal correlation between respiratory syncytial viruses, influenza A, influenza B, metapneumovirus circulation, and KD through an ecological study of respiratory viruses in Chile in 2010&#x02013;2017. <xref rid="t4-cep-2022-00150" ref-type="table">Table 4</xref> summarizes the major studies of viruses as KD-associated pathogens.</p>
<p>Rowley et al. &#x0005b;<xref ref-type="bibr" rid="b58-cep-2022-00150">58</xref>,<xref ref-type="bibr" rid="b59-cep-2022-00150">59</xref>&#x0005d; reported that CD8 T cells, oligoclonal A, and the upregulation of cytotoxic T cell and interferon pathway genes in the coronaries in fatal KD, or identifying cytoplasmic inclusion bodies in ciliated bronchial epithelium, supports a viral etiology, especially of RNA-associated viruses. However, since this requires a highly invasive tissue biopsy in KD patients and advanced molecular techniques, easier and safer tissue sampling methods should be performed.</p>
<p>Farahmand et al. &#x0005b;<xref ref-type="bibr" rid="b60-cep-2022-00150">60</xref>&#x0005d; recently attempted the first systematic review and meta-analysis to investigate the association between different viral infections and KD development. Although some limitations exist in that their research data for acute KD and most studies were conducted in Japan, they found that human parvovirus B19 viremia (odds ratio &#x0005b;OR&#x0005d;, 41.05; 95% confidence interval &#x0005b;CI&#x0005d;, 5.13&#x02013;328.28; I<sup>2</sup>&#x0003d;0%), EBV immunoglobulin M seropositivity (OR, 7.18; 95% CI, 3.65&#x02013;14.12; I<sup>2</sup>&#x0003d;0%), and human herpesvirus 6 immunoglobulin G seropositivity (OR, 5.83; 95% CI, 1.06&#x02013;32.01) were highly suggested as key contributors to the development of KD in children. They also hypothesized that KD is not caused by a single viral pathogen but is likely due to multiple viral pathogen infections.</p>
<p>Meanwhile, the relationship between KD and vaccination has also been reported for hepatitis A, hepatitis B, influenza, and rotavirus vaccines&#x0005b; <xref ref-type="bibr" rid="b62-cep-2022-00150">62</xref>-<xref ref-type="bibr" rid="b67-cep-2022-00150">67</xref>&#x0005d;. Miron et al. &#x0005b;<xref ref-type="bibr" rid="b62-cep-2022-00150">62</xref>&#x0005d; reported KD cases that occurred one day after the second dose of hepatitis B vaccination, and Yin et al. &#x0005b;<xref ref-type="bibr" rid="b63-cep-2022-00150">63</xref>&#x0005d; reported that KD occurred after the second dose of rotavirus vaccine and the first dose of hepatitis A vaccine at the same time. Shimada et al. &#x0005b;<xref ref-type="bibr" rid="b64-cep-2022-00150">64</xref>&#x0005d; raised the possibility of vasculitis due to an autoimmune reaction to an influenza vaccine through a KD case that occurred after receipt of the second dose of influenza vaccine. In particular, Bonetto et al. &#x0005b;<xref ref-type="bibr" rid="b65-cep-2022-00150">65</xref>&#x0005d; reviewed 75 studies of various vaccines and vasculitis over 20 years from 1994 to 2014 and reported that the influenza vaccine is more frequently associated with vasculitis than any other vaccine. However, Hua et al. &#x0005b;<xref ref-type="bibr" rid="b66-cep-2022-00150">66</xref>&#x0005d; reported no evidence that vaccines increased the risk of KD in 107 cases of KD and 23 U.S. Food and Drug Administration&#x02013;licensed vaccines across the United States in 1990&#x02013;2007. Abrams et al. &#x0005b;<xref ref-type="bibr" rid="b67-cep-2022-00150">67</xref>&#x0005d; reported that childhood vaccination was related to a decreased incidence of KD by analyzing data from the Vaccine Safety Datalink of the US in 1996&#x02013;2006. Most recently, Peralta-Amaro et al. &#x0005b;<xref ref-type="bibr" rid="b68-cep-2022-00150">68</xref>&#x0005d; reported a case of atypical KD in adults after COVID-19 vaccination (<xref rid="t5-cep-2022-00150" ref-type="table">Table 5</xref>).</p>
<p>As mentioned above, epidemiological and pathological studies have proposed viruses as the most attractive etiology of KD, but consistent evidence is lacking that any particular virus is the etiology, so research on this topic should continue.</p>
</sec>
<sec>
<title>COVID-19 and KD</title>
<p>Verdoni et al. &#x0005b;<xref ref-type="bibr" rid="b3-cep-2022-00150">3</xref>&#x0005d; initially reported that 10 cases of KLD occurred in just 2 months in Bergamo, Italy, the city hardest hit by COVID-19, increasing by 30-fold compared to 19 cases in the immediately preceding 5 years. Since then, many countries in Europe reported a series of positive responses to SARS-CoV-2 infection in patients with KLD &#x0005b;<xref ref-type="bibr" rid="b69-cep-2022-00150">69</xref>-<xref ref-type="bibr" rid="b72-cep-2022-00150">72</xref>&#x0005d;, raising questions about whether there is a connection between KD and COVID-19. Jones et al. &#x0005b;<xref ref-type="bibr" rid="b69-cep-2022-00150">69</xref>&#x0005d; reported a positive case of COVID-19 in 6-monthold infants with classic KD, and Cazzaniga et al. &#x0005b;<xref ref-type="bibr" rid="b70-cep-2022-00150">70</xref>&#x0005d; reported a positive case in a 6-year-old boy. Renganathan et al. &#x0005b;<xref ref-type="bibr" rid="b71-cep-2022-00150">71</xref>&#x0005d; reported an interesting case of KD recurrence after COVID-19 infection in a 10-year-old boy with a history of KD 4 years prior. Riphagen et al. &#x0005b;<xref ref-type="bibr" rid="b72-cep-2022-00150">72</xref>&#x0005d; reported an unprecedented cluster of 8 children with hyperinflammatory shock, showing features similar to atypical KD, KD shock syndrome (KDSS), or toxic shock syndrome (TSS), during a 10-day period in mid-April 2020, 4 of whom had a family history of COVID-19.</p>
<p>On the other hand, in Asia, the KD prevalence decreased during the same period, raising the same issue of the connection between KD and viral infections, which was assumed to be the effect of thorough social distancing or mask wearing &#x0005b;<xref ref-type="bibr" rid="b4-cep-2022-00150">4</xref>-<xref ref-type="bibr" rid="b6-cep-2022-00150">6</xref>&#x0005d;. Kang et al. &#x0005b;<xref ref-type="bibr" rid="b4-cep-2022-00150">4</xref>&#x0005d; reported a reduction in KD after nonpharmaceutical intervention through an ecological study. Ae et al. &#x0005b;<xref ref-type="bibr" rid="b5-cep-2022-00150">5</xref>&#x0005d; reported that the incidence of KD in 2020 decreased by 35% versus the previous 3 years (2017&#x02013;2019) in Japan; in Taiwan, Yang and Kuo &#x0005b;<xref ref-type="bibr" rid="b6-cep-2022-00150">6</xref>&#x0005d; reported that, in 2020, Taiwan decreased by 30% and 31% compared to 2018 and 2019, respectively. However, the fact that the number of patients with KD or KLD varies widely among regions before and after the COVID-19 pandemic can be a result of differences in regional policies on infectious diseases affecting healthcare access. In other words, the decrease in KD prevalence in Asia may have been an underestimation caused by the COVID-19 pandemic, which reduced access to healthcare. Therefore, further studies are required in the future.</p>
<p>The curiosity about the association between COVID-19 and KD began with reports of clinical features similar to KD, although it sometimes showed a critical course &#x0005b;<xref ref-type="bibr" rid="b73-cep-2022-00150">73</xref>,<xref ref-type="bibr" rid="b74-cep-2022-00150">74</xref>&#x0005d;. This is more often reported in areas where COVID-19 is highly prevalent &#x0005b;<xref ref-type="bibr" rid="b75-cep-2022-00150">75</xref>&#x0005d;, but the new syndrome differs from actual KD; therefore, the World Health Organization and the Centers for Disease Control and Prevention of the US termed it MIS-C &#x0005b;<xref ref-type="bibr" rid="b76-cep-2022-00150">76</xref>&#x0005d;. MIS-C is more common in older age groups than KD; the most frequent clinical features are gastrointestinal or neurological symptoms, and shock is also common, making it difficult to consider it the same disease &#x0005b;<xref ref-type="bibr" rid="b48-cep-2022-00150">48</xref>,<xref ref-type="bibr" rid="b77-cep-2022-00150">77</xref>-<xref ref-type="bibr" rid="b81-cep-2022-00150">81</xref>&#x0005d;. Although there are some overlapping clinical manifestations of COVID-19 and KD, there are also clear distinctions. In South Korea, Kim et al. &#x0005b;<xref ref-type="bibr" rid="b78-cep-2022-00150">78</xref>&#x0005d; reported the first case of MIS-C related to COVID-19 in an 11-year-old boy with clinical features of incomplete KD or KDSS in 2020.</p>
<p>Based on the data published thus far, MIS-C, severe COVID-19 infection without MIS-C, TSS, and KD are compared in <xref rid="t6-cep-2022-00150" ref-type="table">Table 6</xref>. Notably, Rhim et al. &#x0005b;<xref ref-type="bibr" rid="b80-cep-2022-00150">80</xref>&#x0005d; recently introduced the hypothesis that similar diseases associated with infection are based on a common immunopathogenesis, the &#x0201c;protein-homeostasis-system,&#x0201d; although clinical manifestations appear in various forms. In particular, this hypothesis is a new concept of the immune response that occurs in an individual, not only by the pathogen itself but by host cells damaged by infection, and is expected to bring new implications for the ongoing study of KD etiology.</p>
<p>However, Xu et al. &#x0005b;<xref ref-type="bibr" rid="b81-cep-2022-00150">81</xref>&#x0005d; hypothesized that MIS-C due to SARS-CoV-2 infection acts as a &#x0201c;priming trigger,&#x0201d; leading to KD, as strong systemic inflammatory reactions may trigger coronary lesions. Xu et al. &#x0005b;<xref ref-type="bibr" rid="b81-cep-2022-00150">81</xref>&#x0005d; also estimated that the absence of reported KD or KD-like symptoms observed in pediatric patients in China since the COVID-19 outbreak was due to differences in racial backgrounds and genetic susceptibilities. Unlike in Europe, in Korea, Japan, and Taiwan, the prevalence of KD decreased during the COVID-19 pandemic &#x0005b;<xref ref-type="bibr" rid="b4-cep-2022-00150">4</xref>-<xref ref-type="bibr" rid="b6-cep-2022-00150">6</xref>&#x0005d;. This phenomenon is attributed to a decrease in respiratory infections caused by thorough social distancing and mask wearing masks, which strongly suggests that the etiology of KD is related to unidentified respiratory pathogens. This not only reminds us of the importance of ethnic background differences or strengthening respiratory infection control, it suggests that KD can be triggered by more diverse pathogens rather than a single causative pathogen. <xref rid="t7-cep-2022-00150" ref-type="table">Table 7</xref> summarizes case reports of SARS-CoV-2 infection as a KD-related pathogen and studies of its association.</p>
</sec>
<sec sec-type="conclusions">
<title>Conclusion</title>
<p>If the etiology of a disease is unclear, it obscures its prevention, diagnosis, and management. KD can cause serious sequelae in young children in particular; therefore, continuous efforts to determine its etiology are essential. Thus far, the virus has attracted great attention as one etiology of KD, but it remains difficult to identify a single causative pathogen. The role of the virus in KD pathophysiology or identification of the virus as a direct etiology is expected to be clarified through the development of more advanced diagnostic technologies in the future. However, there is no significant disagreement regarding the pathophysiology of KD in that infection with various pathogens, including viruses, triggers a strong inflammatory response in individuals from certain genetic backgrounds. Therefore, in the future, it will be necessary to conduct continuous research on immune responses in patients with KD, including their genetic backgrounds, and identify KD causative factors, including various pathogens.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict"><p><bold>Conflicts of interest</bold></p><p>No potential conflict of interest relevant to this article was reported.</p></fn>
<fn fn-type="financial-disclosure"><p><bold>Funding</bold></p>
<p>This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="b1-cep-2022-00150">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nagata</surname><given-names>S</given-names></name>
</person-group>
<article-title>Causes of Kawasaki disease-from past to present</article-title>
<source>Front Pediatr</source>
<year>2019</year>
<volume>7</volume>
<fpage>18</fpage>
</element-citation></ref>
<ref id="b2-cep-2022-00150">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kawasaki</surname><given-names>T</given-names></name>
</person-group>
<article-title>Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children</article-title>
<source>Arerugi</source>
<year>1967</year>
<volume>16</volume>
<fpage>178</fpage>
<lpage>222</lpage>
</element-citation></ref>
<ref id="b3-cep-2022-00150">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Verdoni</surname><given-names>L</given-names></name>
<name><surname>Mazza</surname><given-names>A</given-names></name>
<name><surname>Gervasoni</surname><given-names>A</given-names></name>
<name><surname>Martelli</surname><given-names>L</given-names></name>
<name><surname>Ruggeri</surname><given-names>M</given-names></name>
<name><surname>Ciuffreda</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study</article-title>
<source>Lancet</source>
<year>2020</year>
<volume>395</volume>
<fpage>1771</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b4-cep-2022-00150">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>JM</given-names></name>
<name><surname>Kim</surname><given-names>YE</given-names></name>
<name><surname>Huh</surname><given-names>K</given-names></name>
<name><surname>Hong</surname><given-names>J</given-names></name>
<name><surname>Kim</surname><given-names>DW</given-names></name>
<name><surname>Kim</surname><given-names>MY</given-names></name>
<etal/>
</person-group>
<article-title>Reduction in Kawasaki disease after nonpharmaceutical interventions in the COVID-19 era: a nationwide observational study in Korea</article-title>
<source>Circulation</source>
<year>2021</year>
<volume>143</volume>
<fpage>2508</fpage>
<lpage>10</lpage>
</element-citation></ref>
<ref id="b5-cep-2022-00150">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ae</surname><given-names>R</given-names></name>
<name><surname>Shibata</surname><given-names>Y</given-names></name>
<name><surname>Kosami</surname><given-names>K</given-names></name>
<name><surname>Nakamura</surname><given-names>Y</given-names></name>
<name><surname>Hamada</surname><given-names>H</given-names></name>
</person-group>
<article-title>Kawasaki disease and pediatric infectious diseases during the coronavirus disease 2019 pandemic</article-title>
<source>J Pediatr</source>
<year>2021</year>
<volume>239</volume>
<fpage>50</fpage>
<lpage>8</lpage>
<comment>e2</comment>
</element-citation></ref>
<ref id="b6-cep-2022-00150">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>YL</given-names></name>
<name><surname>Kuo</surname><given-names>HC</given-names></name>
</person-group>
<article-title>Public health interventions for COVID-19 reduce Kawasaki disease in Taiwan</article-title>
<source>Children (Basel)</source>
<year>2021</year>
<volume>8</volume>
<fpage>623</fpage>
</element-citation></ref>
<ref id="b7-cep-2022-00150">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Choi</surname><given-names>JW</given-names></name>
</person-group>
<article-title>Can we get a clue for the etiology of Kawasaki disease in the COVID-19 pandemic?</article-title>
<source>Clin Exp Pediatr</source>
<year>2020</year>
<volume>63</volume>
<fpage>335</fpage>
<lpage>6</lpage>
</element-citation></ref>
<ref id="b8-cep-2022-00150">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kwak</surname><given-names>JH</given-names></name>
<name><surname>Lee</surname><given-names>SY</given-names></name>
<name><surname>Choi</surname><given-names>JW</given-names></name>
<collab>Korean Society of Kawasaki Disease</collab>
</person-group>
<article-title>Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019</article-title>
<source>Clin Exp Pediatr</source>
<year>2021</year>
<volume>64</volume>
<fpage>68</fpage>
<lpage>75</lpage>
</element-citation></ref>
<ref id="b9-cep-2022-00150">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kok</surname><given-names>HC</given-names></name>
<name><surname>Nair</surname><given-names>D</given-names></name>
<name><surname>Wong</surname><given-names>KJ</given-names></name>
<name><surname>Fong</surname><given-names>SM</given-names></name>
</person-group>
<article-title>Multisystem inflammatory syndrome in children and Kawasaki disease in infants: 2 sides of the same coin?</article-title>
<source>Clin Exp Pediatr</source>
<year>2021</year>
<volume>64</volume>
<fpage>599</fpage>
<lpage>601</lpage>
</element-citation></ref>
<ref id="b10-cep-2022-00150">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Feldstein</surname><given-names>LR</given-names></name>
<name><surname>Rose</surname><given-names>EB</given-names></name>
<name><surname>Horwitz</surname><given-names>SM</given-names></name>
<name><surname>Collins</surname><given-names>JP</given-names></name>
<name><surname>Newhams</surname><given-names>MM</given-names></name>
<name><surname>Son</surname><given-names>MBF</given-names></name>
<etal/>
</person-group>
<article-title>Multisystem inflammatory syndrome in U.S. children and adolescents</article-title>
<source>N Engl J Med</source>
<year>2020</year>
<volume>383</volume>
<fpage>334</fpage>
<lpage>46</lpage>
</element-citation></ref>
<ref id="b11-cep-2022-00150">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fabi</surname><given-names>M</given-names></name>
<name><surname>Filice</surname><given-names>E</given-names></name>
<name><surname>Andreozzi</surname><given-names>L</given-names></name>
<name><surname>Conti</surname><given-names>F</given-names></name>
<name><surname>Gabrielli</surname><given-names>L</given-names></name>
<name><surname>Balducci</surname><given-names>A</given-names></name>
<etal/>
</person-group>
<article-title>Spectrum of cardiovascular diseases in children during high peak coronavirus disease 2019 period infection in Northern Italy: is there a link?</article-title>
<source>J Pediatric Infect Dis Soc</source>
<year>2021</year>
<volume>10</volume>
<fpage>714</fpage>
<lpage>21</lpage>
</element-citation></ref>
<ref id="b12-cep-2022-00150">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Swann</surname><given-names>OV</given-names></name>
<name><surname>Holden</surname><given-names>KA</given-names></name>
<name><surname>Turtle</surname><given-names>L</given-names></name>
<name><surname>Pollock</surname><given-names>L</given-names></name>
<name><surname>Fairfield</surname><given-names>CJ</given-names></name>
<name><surname>Drake</surname><given-names>TM</given-names></name>
<etal/>
</person-group>
<article-title>Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study</article-title>
<source>BMJ</source>
<year>2020</year>
<volume>370</volume>
<fpage>m3249</fpage>
</element-citation></ref>
<ref id="b13-cep-2022-00150">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fujita</surname><given-names>Y</given-names></name>
<name><surname>Nakamura</surname><given-names>Y</given-names></name>
<name><surname>Sakata</surname><given-names>K</given-names></name>
<name><surname>Hara</surname><given-names>N</given-names></name>
<name><surname>Kobayashi</surname><given-names>M</given-names></name>
<name><surname>Nagai</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Kawasaki disease in families</article-title>
<source>Pediatrics</source>
<year>1989</year>
<volume>84</volume>
<fpage>666</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b14-cep-2022-00150">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Uehara</surname><given-names>R</given-names></name>
<name><surname>Yashiro</surname><given-names>M</given-names></name>
<name><surname>Nakamura</surname><given-names>Y</given-names></name>
<name><surname>Yanagawa</surname><given-names>H</given-names></name>
</person-group>
<article-title>Clinical features of patients with Kawasaki disease whose parents had the same disease</article-title>
<source>Arch Pediatr Adolesc Med</source>
<year>2004</year>
<volume>158</volume>
<fpage>1166</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b15-cep-2022-00150">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Makino</surname><given-names>N</given-names></name>
<name><surname>Nakamura</surname><given-names>Y</given-names></name>
<name><surname>Yashiro</surname><given-names>M</given-names></name>
<name><surname>Kosami</surname><given-names>K</given-names></name>
<name><surname>Matsubara</surname><given-names>Y</given-names></name>
<name><surname>Ae</surname><given-names>R</given-names></name>
<etal/>
</person-group>
<article-title>Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016</article-title>
<source>Pediatr Int</source>
<year>2019</year>
<volume>61</volume>
<fpage>397</fpage>
<lpage>403</lpage>
</element-citation></ref>
<ref id="b16-cep-2022-00150">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yanagawa</surname><given-names>H</given-names></name>
<name><surname>Nakamura</surname><given-names>Y</given-names></name>
<name><surname>Kawasaki</surname><given-names>T</given-names></name>
<name><surname>Shigematsu</surname><given-names>I</given-names></name>
</person-group>
<article-title>Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86</article-title>
<source>Lancet</source>
<year>1986</year>
<volume>2</volume>
<fpage>1138</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b17-cep-2022-00150">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lim</surname><given-names>JH</given-names></name>
<name><surname>Kim</surname><given-names>YK</given-names></name>
<name><surname>Min</surname><given-names>SH</given-names></name>
<name><surname>Kim</surname><given-names>SW</given-names></name>
<name><surname>Lee</surname><given-names>YH</given-names></name>
<name><surname>Lee</surname><given-names>JM</given-names></name>
</person-group>
<article-title>Seasonal trends of viral prevalence and incidence of Kawasaki disease: a Korea public health data analysis</article-title>
<source>J Clin Med</source>
<year>2021</year>
<volume>10</volume>
<fpage>3301</fpage>
</element-citation></ref>
<ref id="b18-cep-2022-00150">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>JM</given-names></name>
<name><surname>Jung</surname><given-names>J</given-names></name>
<name><surname>Kim</surname><given-names>YE</given-names></name>
<name><surname>Huh</surname><given-names>K</given-names></name>
<name><surname>Hong</surname><given-names>J</given-names></name>
<name><surname>Kim</surname><given-names>DW</given-names></name>
<etal/>
</person-group>
<article-title>Temporal correlation between Kawasaki disease and infectious diseases in South Korea</article-title>
<source>JAMA Netw Open</source>
<year>2022</year>
<volume>5</volume>
<elocation-id>e2147363</elocation-id>
</element-citation></ref>
<ref id="b19-cep-2022-00150">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rowley</surname><given-names>AH</given-names></name>
</person-group>
<article-title>Is Kawasaki disease an infectious disorder?</article-title>
<source>Int J Rheum Dis</source>
<year>2018</year>
<volume>21</volume>
<fpage>20</fpage>
<lpage>5</lpage>
</element-citation></ref>
<ref id="b20-cep-2022-00150">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Leung</surname><given-names>DY</given-names></name>
<name><surname>Meissner</surname><given-names>HC</given-names></name>
<name><surname>Fulton</surname><given-names>DR</given-names></name>
<name><surname>Murray</surname><given-names>DL</given-names></name>
<name><surname>Kotzin</surname><given-names>BL</given-names></name>
<name><surname>Schlievert</surname><given-names>PM</given-names></name>
</person-group>
<article-title>Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome</article-title>
<source>Lancet</source>
<year>1993</year>
<volume>342</volume>
<fpage>1385</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b21-cep-2022-00150">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wann</surname><given-names>ER</given-names></name>
<name><surname>Fehringer</surname><given-names>AP</given-names></name>
<name><surname>Ezepchuk</surname><given-names>YV</given-names></name>
<name><surname>Schlievert</surname><given-names>PM</given-names></name>
<name><surname>Bina</surname><given-names>P</given-names></name>
<name><surname>Reiser</surname><given-names>RF</given-names></name>
<etal/>
</person-group>
<article-title>Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A</article-title>
<source>Infect Immun</source>
<year>1999</year>
<volume>67</volume>
<fpage>4737</fpage>
<lpage>43</lpage>
</element-citation></ref>
<ref id="b22-cep-2022-00150">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Matsubara</surname><given-names>K</given-names></name>
<name><surname>Fukaya</surname><given-names>T</given-names></name>
</person-group>
<article-title>The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease</article-title>
<source>Curr Opin Infect Dis</source>
<year>2007</year>
<volume>20</volume>
<fpage>298</fpage>
<lpage>303</lpage>
</element-citation></ref>
<ref id="b23-cep-2022-00150">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshioka</surname><given-names>T</given-names></name>
<name><surname>Matsutani</surname><given-names>T</given-names></name>
<name><surname>Toyosaki-Maeda</surname><given-names>T</given-names></name>
<name><surname>Suzuki</surname><given-names>H</given-names></name>
<name><surname>Uemura</surname><given-names>S</given-names></name>
<name><surname>Suzuki</surname><given-names>R</given-names></name>
<etal/>
</person-group>
<article-title>Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease</article-title>
<source>Pediatr Res</source>
<year>2003</year>
<volume>53</volume>
<fpage>403</fpage>
<lpage>10</lpage>
</element-citation></ref>
<ref id="b24-cep-2022-00150">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Konishi</surname><given-names>N</given-names></name>
<name><surname>Baba</surname><given-names>K</given-names></name>
<name><surname>Abe</surname><given-names>J</given-names></name>
<name><surname>Maruko</surname><given-names>T</given-names></name>
<name><surname>Waki</surname><given-names>K</given-names></name>
<name><surname>Takeda</surname><given-names>N</given-names></name>
<etal/>
</person-group>
<article-title>A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection</article-title>
<source>Acta Paediatr</source>
<year>1997</year>
<volume>86</volume>
<fpage>661</fpage>
<lpage>4</lpage>
</element-citation></ref>
<ref id="b25-cep-2022-00150">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Johnson</surname><given-names>D</given-names></name>
<name><surname>Azimi</surname><given-names>P</given-names></name>
</person-group>
<article-title>Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection</article-title>
<source>Pediatr Infect Dis</source>
<year>1985</year>
<volume>4</volume>
<fpage>100</fpage>
</element-citation></ref>
<ref id="b26-cep-2022-00150">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Keren</surname><given-names>G</given-names></name>
<name><surname>Barzilay</surname><given-names>Z</given-names></name>
<name><surname>Alpert</surname><given-names>G</given-names></name>
<name><surname>Spirer</surname><given-names>Z</given-names></name>
<name><surname>Danon</surname><given-names>Y</given-names></name>
</person-group>
<article-title>Mucocutaneous lymph node syndrome (Kawasaki dIsease) in Israel. A review of 13 cases: is pseudomonas infection responsible?</article-title>
<source>Acta Paediatr Scand</source>
<year>1983</year>
<volume>72</volume>
<fpage>455</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b27-cep-2022-00150">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Normann</surname><given-names>E</given-names></name>
<name><surname>N&#x000e4;&#x000e4;s</surname><given-names>J</given-names></name>
<name><surname>Gnarpe</surname><given-names>J</given-names></name>
<name><surname>B&#x000e4;ckman</surname><given-names>H</given-names></name>
<name><surname>Gnarpe</surname><given-names>H</given-names></name>
</person-group>
<article-title>Demonstration of Chlamydia pneumoniae in cardiovascular tissues from children with Kawasaki disease</article-title>
<source>Pediatr Infect Dis J</source>
<year>1999</year>
<volume>18</volume>
<fpage>72</fpage>
<lpage>3</lpage>
</element-citation></ref>
<ref id="b28-cep-2022-00150">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tang</surname><given-names>Y</given-names></name>
<name><surname>Yan</surname><given-names>W</given-names></name>
<name><surname>Sun</surname><given-names>L</given-names></name>
<name><surname>Huang</surname><given-names>J</given-names></name>
<name><surname>Qian</surname><given-names>W</given-names></name>
<name><surname>Hou</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Kawasaki disease associated with Mycoplasma pneumoniae</article-title>
<source>Ital J Pediatr</source>
<year>2016</year>
<volume>42</volume>
<fpage>83</fpage>
</element-citation></ref>
<ref id="b29-cep-2022-00150">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kafetzis</surname><given-names>DA</given-names></name>
<name><surname>Maltezou</surname><given-names>HC</given-names></name>
<name><surname>Constantopoulou</surname><given-names>I</given-names></name>
<name><surname>Antonaki</surname><given-names>G</given-names></name>
<name><surname>Liapi</surname><given-names>G</given-names></name>
<name><surname>Mathioudakis</surname><given-names>I</given-names></name>
</person-group>
<article-title>Lack of association between Kawasaki syndrome and infection with Rickettsia conorii, Rickettsia typhi, Coxiella burnetii or Ehrlichia phagocytophila group</article-title>
<source>Pediatr Infect Dis J</source>
<year>2001</year>
<volume>20</volume>
<fpage>703</fpage>
<lpage>6</lpage>
</element-citation></ref>
<ref id="b30-cep-2022-00150">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Okano</surname><given-names>M</given-names></name>
<name><surname>Thiele</surname><given-names>GM</given-names></name>
<name><surname>Sakiyama</surname><given-names>Y</given-names></name>
<name><surname>Matsumoto</surname><given-names>S</given-names></name>
<name><surname>Purtilo</surname><given-names>DT</given-names></name>
</person-group>
<article-title>Adenovirus infection in patients with Kawasaki disease</article-title>
<source>J Med Virol</source>
<year>1990</year>
<volume>32</volume>
<fpage>53</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b31-cep-2022-00150">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rosenfeld</surname><given-names>N</given-names></name>
<name><surname>Tasher</surname><given-names>D</given-names></name>
<name><surname>Ovadia</surname><given-names>A</given-names></name>
<name><surname>Abiri</surname><given-names>S</given-names></name>
<name><surname>Dalal</surname><given-names>I</given-names></name>
</person-group>
<article-title>Kawasaki disease with a concomitant primary Epstein - Barr virus infection</article-title>
<source>Pediatr Rheumatol Online J</source>
<year>2020</year>
<volume>18</volume>
<fpage>65</fpage>
</element-citation></ref>
<ref id="b32-cep-2022-00150">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kanegane</surname><given-names>H</given-names></name>
<name><surname>Tsuji</surname><given-names>T</given-names></name>
<name><surname>Seki</surname><given-names>H</given-names></name>
<name><surname>Yachie</surname><given-names>A</given-names></name>
<name><surname>Yokoi</surname><given-names>T</given-names></name>
<name><surname>Miyawaki</surname><given-names>T</given-names></name>
<etal/>
</person-group>
<article-title>Kawasaki disease with a concomitant primary Epstein-Barr virus infection</article-title>
<source>Acta Paediatr Jpn</source>
<year>1994</year>
<volume>36</volume>
<fpage>713</fpage>
<lpage>6</lpage>
</element-citation></ref>
<ref id="b33-cep-2022-00150">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Holm</surname><given-names>JM</given-names></name>
<name><surname>Hansen</surname><given-names>LK</given-names></name>
<name><surname>Oxh&#x000f8;j</surname><given-names>H</given-names></name>
</person-group>
<article-title>Kawasaki disease associated with parvovirus B19 infection</article-title>
<source>Eur J Pediatr</source>
<year>1995</year>
<volume>154</volume>
<fpage>633</fpage>
<lpage>4</lpage>
</element-citation></ref>
<ref id="b34-cep-2022-00150">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Okano</surname><given-names>M</given-names></name>
<name><surname>Luka</surname><given-names>J</given-names></name>
<name><surname>Thiele</surname><given-names>GM</given-names></name>
<name><surname>Sakiyama</surname><given-names>Y</given-names></name>
<name><surname>Matsumoto</surname><given-names>S</given-names></name>
<name><surname>Purtilo</surname><given-names>DT</given-names></name>
</person-group>
<article-title>Human herpesvirus 6 infection and Kawasaki disease</article-title>
<source>J Clin Microbiol</source>
<year>1989</year>
<volume>27</volume>
<fpage>2379</fpage>
<lpage>80</lpage>
</element-citation></ref>
<ref id="b35-cep-2022-00150">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Enders</surname><given-names>G</given-names></name>
<name><surname>Biber</surname><given-names>M</given-names></name>
<name><surname>Meyer</surname><given-names>G</given-names></name>
<name><surname>Helftenbein</surname><given-names>E</given-names></name>
</person-group>
<article-title>Prevalence of antibodies to human herpesvirus 6 in different age groups, in children with exanthema subitum, other acute exanthematous childhood diseases, Kawasaki syndrome, and acute infections with other herpesviruses and HIV</article-title>
<source>Infection</source>
<year>1990</year>
<volume>18</volume>
<fpage>12</fpage>
<lpage>5</lpage>
</element-citation></ref>
<ref id="b36-cep-2022-00150">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Matsuno</surname><given-names>S</given-names></name>
<name><surname>Utagawa</surname><given-names>E</given-names></name>
<name><surname>Sugiura</surname><given-names>A</given-names></name>
</person-group>
<article-title>Association of rotavirus infection with Kawasaki syndrome</article-title>
<source>J Infect Dis</source>
<year>1983</year>
<volume>148</volume>
<fpage>177</fpage>
</element-citation></ref>
<ref id="b37-cep-2022-00150">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kuijpers</surname><given-names>TW</given-names></name>
<name><surname>Herweijer</surname><given-names>TJ</given-names></name>
<name><surname>Sch&#x000f6;lvinck</surname><given-names>L</given-names></name>
<name><surname>Wertheim-Van Dillen</surname><given-names>PM</given-names></name>
<name><surname>Van De Veer</surname><given-names>EM</given-names></name>
</person-group>
<article-title>Kawasaki disease associated with measles virus infection in a monozygotic twin</article-title>
<source>Pediatr Infect Dis J</source>
<year>2000</year>
<volume>19</volume>
<fpage>350</fpage>
<lpage>3</lpage>
</element-citation></ref>
<ref id="b38-cep-2022-00150">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>S</given-names></name>
<name><surname>Jat</surname><given-names>KR</given-names></name>
<name><surname>Suri</surname><given-names>D</given-names></name>
<name><surname>Ratho</surname><given-names>RK</given-names></name>
</person-group>
<article-title>Dengue fever and Kawasaki disease: a clinical dilemma</article-title>
<source>Rheumatol Int</source>
<year>2009</year>
<volume>29</volume>
<fpage>717</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b39-cep-2022-00150">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>DH</given-names></name>
<name><surname>Huang</surname><given-names>HP</given-names></name>
</person-group>
<article-title>Kawasaki disease associated with chickenpox: report of two sibling cases</article-title>
<source>Acta Paediatr Taiwan</source>
<year>2004</year>
<volume>45</volume>
<fpage>94</fpage>
<lpage>6</lpage>
</element-citation></ref>
<ref id="b40-cep-2022-00150">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Belostotsky</surname><given-names>O</given-names></name>
<name><surname>Chowdhury</surname><given-names>D</given-names></name>
<name><surname>Schuval</surname><given-names>SJ</given-names></name>
</person-group>
<article-title>Atypical Kawasaki disease in an HIV-infected adolescent</article-title>
<source>J Allergy Clin Immunol</source>
<year>2004</year>
<volume>113</volume>
<issue>2 Suppl</issue>
<fpage>S126</fpage>
</element-citation></ref>
<ref id="b41-cep-2022-00150">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shirato</surname><given-names>K</given-names></name>
<name><surname>Imada</surname><given-names>Y</given-names></name>
<name><surname>Kawase</surname><given-names>M</given-names></name>
<name><surname>Nakagaki</surname><given-names>K</given-names></name>
<name><surname>Matsuyama</surname><given-names>S</given-names></name>
<name><surname>Taguchi</surname><given-names>F</given-names></name>
</person-group>
<article-title>Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease</article-title>
<source>J Med Virol</source>
<year>2014</year>
<volume>86</volume>
<fpage>2146</fpage>
<lpage>53</lpage>
</element-citation></ref>
<ref id="b42-cep-2022-00150">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Catalano-Pons</surname><given-names>C</given-names></name>
<name><surname>Giraud</surname><given-names>C</given-names></name>
<name><surname>Rozenberg</surname><given-names>F</given-names></name>
<name><surname>Meritet</surname><given-names>JF</given-names></name>
<name><surname>Lebon</surname><given-names>P</given-names></name>
<name><surname>Gendrel</surname><given-names>D</given-names></name>
</person-group>
<article-title>Detection of human bocavirus in children with Kawasaki disease</article-title>
<source>Clin Microbiol Infect</source>
<year>2007</year>
<volume>13</volume>
<fpage>1220</fpage>
<lpage>2</lpage>
</element-citation></ref>
<ref id="b43-cep-2022-00150">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Giray</surname><given-names>T</given-names></name>
<name><surname>Bi&#x000e7;er</surname><given-names>S</given-names></name>
<name><surname>K&#x000fc;&#x000e7;&#x000fc;k</surname><given-names>&#x000d6;</given-names></name>
<name><surname>&#x000c7;&#x000f6;l</surname><given-names>D</given-names></name>
<name><surname>Yalva&#x000e7;</surname><given-names>Z</given-names></name>
<name><surname>G&#x000fc;rol</surname><given-names>Y</given-names></name>
<etal/>
</person-group>
<article-title>Four cases with Kawasaki disease and viral infection: aetiology or association</article-title>
<source>Infez Med</source>
<year>2016</year>
<volume>24</volume>
<fpage>340</fpage>
<lpage>4</lpage>
</element-citation></ref>
<ref id="b44-cep-2022-00150">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname><given-names>E</given-names></name>
<name><surname>Kajon</surname><given-names>AE</given-names></name>
<name><surname>Wang</surname><given-names>H</given-names></name>
<name><surname>Salamon</surname><given-names>D</given-names></name>
<name><surname>Texter</surname><given-names>K</given-names></name>
<name><surname>Ramilo</surname><given-names>O</given-names></name>
<etal/>
</person-group>
<article-title>Clinical and virologic characteristics may aid distinction of acute adenovirus disease from Kawasaki disease with incidental adenovirus detection</article-title>
<source>J Pediatr</source>
<year>2016</year>
<volume>170</volume>
<fpage>325</fpage>
<lpage>30</lpage>
</element-citation></ref>
<ref id="b45-cep-2022-00150">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Thissen</surname><given-names>JB</given-names></name>
<name><surname>Isshiki</surname><given-names>M</given-names></name>
<name><surname>Jaing</surname><given-names>C</given-names></name>
<name><surname>Nagao</surname><given-names>Y</given-names></name>
<name><surname>Lebron Aldea</surname><given-names>D</given-names></name>
<name><surname>Allen</surname><given-names>JE</given-names></name>
<etal/>
</person-group>
<article-title>A novel variant of torque teno virus 7 identified in patients with Kawasaki disease</article-title>
<source>PLoS One</source>
<year>2018</year>
<volume>13</volume>
<elocation-id>e0209683</elocation-id>
</element-citation></ref>
<ref id="b46-cep-2022-00150">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Sun</surname><given-names>F</given-names></name>
<name><surname>Deng</surname><given-names>HL</given-names></name>
<name><surname>Liu</surname><given-names>RQ</given-names></name>
</person-group>
<article-title>Influenza A (H1N1) pdm09 virus infection in a patient with incomplete Kawasaki disease: a case report</article-title>
<source>Medicine (Baltimore)</source>
<year>2019</year>
<volume>98</volume>
<elocation-id>e15009</elocation-id>
</element-citation></ref>
<ref id="b47-cep-2022-00150">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Choe</surname><given-names>SA</given-names></name>
<name><surname>An</surname><given-names>HS</given-names></name>
<name><surname>Choe</surname><given-names>YJ</given-names></name>
</person-group>
<article-title>No temporal association between human coronavirus and Kawasaki disease: national data from South Korea</article-title>
<source>J Med Virol</source>
<year>2021</year>
<volume>93</volume>
<fpage>585</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b48-cep-2022-00150">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rowley</surname><given-names>AH</given-names></name>
<name><surname>Shulman</surname><given-names>ST</given-names></name>
<name><surname>Arditi</surname><given-names>M</given-names></name>
</person-group>
<article-title>Immune pathogenesis of COVID-19-related multisystem inflammatory syndrome in children</article-title>
<source>J Clin Invest</source>
<year>2020</year>
<volume>130</volume>
<fpage>5619</fpage>
<lpage>21</lpage>
</element-citation></ref>
<ref id="b49-cep-2022-00150">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>CL</given-names></name>
<name><surname>Wu</surname><given-names>YT</given-names></name>
<name><surname>Liu</surname><given-names>CA</given-names></name>
<name><surname>Kuo</surname><given-names>HC</given-names></name>
<name><surname>Yang</surname><given-names>KD</given-names></name>
</person-group>
<article-title>Kawasaki disease: infection, immunity and genetics</article-title>
<source>Pediatr Infect Dis J</source>
<year>2005</year>
<volume>24</volume>
<fpage>998</fpage>
<lpage>1004</lpage>
</element-citation></ref>
<ref id="b50-cep-2022-00150">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fern&#x000e1;ndez-Cooke</surname><given-names>E</given-names></name>
<name><surname>Tasc&#x000f3;n</surname><given-names>AB</given-names></name>
<name><surname>Ant&#x000f3;n-L&#x000f3;pez</surname><given-names>J</given-names></name>
<name><surname>Grasa Lozano</surname><given-names>CD</given-names></name>
<name><surname>S&#x000e1;nchez-Manubens</surname><given-names>J</given-names></name>
<name><surname>Calvo</surname><given-names>C</given-names></name>
<etal/>
</person-group>
<article-title>Previous or coincident infections with suspected Kawasaki disease. Should we change our approach?</article-title>
<source>An Pediatr (Engl Ed)</source>
<year>2019</year>
<volume>90</volume>
<fpage>213</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b51-cep-2022-00150">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Quiat</surname><given-names>D</given-names></name>
<name><surname>Kula</surname><given-names>T</given-names></name>
<name><surname>Shimizu</surname><given-names>C</given-names></name>
<name><surname>Kanegaye</surname><given-names>JT</given-names></name>
<name><surname>Tremoulet</surname><given-names>AH</given-names></name>
<name><surname>Pitkowsky</surname><given-names>Z</given-names></name>
<etal/>
</person-group>
<article-title>High-throughput screening of Kawasaki disease sera for antiviral antibodies</article-title>
<source>J Infect Dis</source>
<year>2020</year>
<volume>222</volume>
<fpage>1853</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b52-cep-2022-00150">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Aguirre</surname><given-names>D</given-names></name>
<name><surname>Cerda</surname><given-names>J</given-names></name>
<name><surname>Perret</surname><given-names>C</given-names></name>
<name><surname>Borzutzky</surname><given-names>A</given-names></name>
<name><surname>Hoyos-Bachiloglu</surname><given-names>R</given-names></name>
</person-group>
<article-title>Asociaci&#x000f3;n temporal entre la circulaci&#x000f3;n de virus respiratorios y hospitalizaciones por enfermedad de Kawasaki Temporal association between the circulation of respiratory viruses and hospitalizations due to Kawasaki disease</article-title>
<source>Rev Chilena Infectol</source>
<year>2021</year>
<volume>38</volume>
<fpage>152</fpage>
<lpage>60</lpage>
</element-citation></ref>
<ref id="b53-cep-2022-00150">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Takahashi</surname><given-names>K</given-names></name>
<name><surname>Oharaseki</surname><given-names>T</given-names></name>
<name><surname>Naoe</surname><given-names>S</given-names></name>
<name><surname>Yamada</surname><given-names>H</given-names></name>
<name><surname>Murata</surname><given-names>H</given-names></name>
<name><surname>Wakayama</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Candida albicans &#x02013; extract causing systemic vasculitis in mice as an animal model of Kawasaki disease</article-title>
<source>Pediatr Res</source>
<year>2003</year>
<volume>53</volume>
<fpage>175</fpage>
</element-citation></ref>
<ref id="b54-cep-2022-00150">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rod&#x000f3;</surname><given-names>X</given-names></name>
<name><surname>Curcoll</surname><given-names>R</given-names></name>
<name><surname>Robinson</surname><given-names>M</given-names></name>
<name><surname>Ballester</surname><given-names>J</given-names></name>
<name><surname>Burns</surname><given-names>JC</given-names></name>
<name><surname>Cayan</surname><given-names>DR</given-names></name>
<etal/>
</person-group>
<article-title>Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2014</year>
<volume>111</volume>
<fpage>7952</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b55-cep-2022-00150">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>SM</given-names></name>
<name><surname>Huang</surname><given-names>SH</given-names></name>
<name><surname>Weng</surname><given-names>KP</given-names></name>
<name><surname>Chien</surname><given-names>KJ</given-names></name>
<name><surname>Lin</surname><given-names>CC</given-names></name>
<name><surname>Huang</surname><given-names>YF</given-names></name>
</person-group>
<article-title>Update on association between Kawasaki disease and infection</article-title>
<source>J Chin Med Assoc</source>
<year>2019</year>
<volume>82</volume>
<fpage>172</fpage>
<lpage>4</lpage>
</element-citation></ref>
<ref id="b56-cep-2022-00150">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chang</surname><given-names>LY</given-names></name>
<name><surname>Lu</surname><given-names>CY</given-names></name>
<name><surname>Shao</surname><given-names>PL</given-names></name>
<name><surname>Lee</surname><given-names>PI</given-names></name>
<name><surname>Lin</surname><given-names>MT</given-names></name>
<name><surname>Fan</surname><given-names>TY</given-names></name>
<etal/>
</person-group>
<article-title>Viral infections associated with Kawasaki disease</article-title>
<source>J Formos Med Assoc</source>
<year>2014</year>
<volume>113</volume>
<fpage>148</fpage>
<lpage>54</lpage>
</element-citation></ref>
<ref id="b57-cep-2022-00150">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Uehara</surname><given-names>R</given-names></name>
<name><surname>Belay</surname><given-names>ED</given-names></name>
</person-group>
<article-title>Epidemiology of Kawasaki disease in Asia, Europe, and the United States</article-title>
<source>J Epidemiol</source>
<year>2012</year>
<volume>22</volume>
<fpage>79</fpage>
<lpage>85</lpage>
</element-citation></ref>
<ref id="b58-cep-2022-00150">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rowley</surname><given-names>AH</given-names></name>
<name><surname>Baker</surname><given-names>SC</given-names></name>
<name><surname>Shulman</surname><given-names>ST</given-names></name>
<name><surname>Rand</surname><given-names>KH</given-names></name>
<name><surname>Tretiakova</surname><given-names>MS</given-names></name>
<name><surname>Perlman</surname><given-names>EJ</given-names></name>
<etal/>
</person-group>
<article-title>Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a &quot;new&quot; virus associated with Kawasaki disease</article-title>
<source>J Infect Dis</source>
<year>2011</year>
<volume>203</volume>
<fpage>1021</fpage>
<lpage>30</lpage>
</element-citation></ref>
<ref id="b59-cep-2022-00150">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rowley</surname><given-names>AH</given-names></name>
<name><surname>Shulman</surname><given-names>ST</given-names></name>
</person-group>
<article-title>The epidemiology and pathogenesis of Kawasaki disease</article-title>
<source>Front Pediatr</source>
<year>2018</year>
<volume>6</volume>
<fpage>374</fpage>
</element-citation></ref>
<ref id="b60-cep-2022-00150">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Farahmand</surname><given-names>M</given-names></name>
<name><surname>Ahmadi-Vasmehjani</surname><given-names>A</given-names></name>
<name><surname>Esteghamati</surname><given-names>A</given-names></name>
<name><surname>Sayyahfar</surname><given-names>S</given-names></name>
<name><surname>Minaeian</surname><given-names>S</given-names></name>
<name><surname>Khanaliha</surname><given-names>K</given-names></name>
<etal/>
</person-group>
<article-title>A meta-analysis on association between viral infections and Kawasaki disease in children</article-title>
<source>Future Virol</source>
<year>2021</year>
<volume>16</volume>
<fpage>27</fpage>
<lpage>41</lpage>
</element-citation></ref>
<ref id="b61-cep-2022-00150">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nakamura</surname><given-names>A</given-names></name>
<name><surname>Ikeda</surname><given-names>K</given-names></name>
<name><surname>Hamaoka</surname><given-names>K</given-names></name>
</person-group>
<article-title>Aetiological significance of infectious stimuli in Kawasaki disease</article-title>
<source>Front Pediatr</source>
<year>2019</year>
<volume>7</volume>
<fpage>244</fpage>
</element-citation></ref>
<ref id="b62-cep-2022-00150">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Miron</surname><given-names>D</given-names></name>
<name><surname>Fink</surname><given-names>D</given-names></name>
<name><surname>Hashkes</surname><given-names>PJ</given-names></name>
</person-group>
<article-title>Kawasaki disease in an infant following immunisation with hepatitis B vaccine</article-title>
<source>Clin Rheumatol</source>
<year>2003</year>
<volume>22</volume>
<fpage>461</fpage>
<lpage>3</lpage>
</element-citation></ref>
<ref id="b63-cep-2022-00150">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yin</surname><given-names>S</given-names></name>
<name><surname>Liubao</surname><given-names>P</given-names></name>
<name><surname>Chongqing</surname><given-names>T</given-names></name>
<name><surname>Xiaomin</surname><given-names>W</given-names></name>
</person-group>
<article-title>The first case of Kawasaki disease in a 20-month old baby following immunization with rotavirus vaccine and hepatitis A vaccine in China: a case report</article-title>
<source>Hum Vaccin Immunother</source>
<year>2015</year>
<volume>11</volume>
<fpage>2740</fpage>
<lpage>3</lpage>
</element-citation></ref>
<ref id="b64-cep-2022-00150">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shimada</surname><given-names>S</given-names></name>
<name><surname>Watanabe</surname><given-names>T</given-names></name>
<name><surname>Sato</surname><given-names>S</given-names></name>
</person-group>
<article-title>A patient with Kawasaki disease following influenza vaccinations</article-title>
<source>Pediatr Infect Dis J</source>
<year>2015</year>
<volume>34</volume>
<fpage>913</fpage>
</element-citation></ref>
<ref id="b65-cep-2022-00150">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bonetto</surname><given-names>C</given-names></name>
<name><surname>Trotta</surname><given-names>F</given-names></name>
<name><surname>Felicetti</surname><given-names>P</given-names></name>
<name><surname>Alarc&#x000f3;n</surname><given-names>GS</given-names></name>
<name><surname>Santuccio</surname><given-names>C</given-names></name>
<name><surname>Bachtiar</surname><given-names>NS</given-names></name>
<etal/>
</person-group>
<article-title>Vasculitis as an adverse event following immunization - systematic literature review</article-title>
<source>Vaccine</source>
<year>2016</year>
<volume>34</volume>
<fpage>6641</fpage>
<lpage>51</lpage>
</element-citation></ref>
<ref id="b66-cep-2022-00150">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hua</surname><given-names>W</given-names></name>
<name><surname>Izurieta</surname><given-names>HS</given-names></name>
<name><surname>Slade</surname><given-names>B</given-names></name>
<name><surname>Belay</surname><given-names>ED</given-names></name>
<name><surname>Haber</surname><given-names>P</given-names></name>
<name><surname>Tiernan</surname><given-names>R</given-names></name>
<etal/>
</person-group>
<article-title>Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007</article-title>
<source>Pediatr Infect Dis J</source>
<year>2009</year>
<volume>28</volume>
<fpage>943</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b67-cep-2022-00150">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Abrams</surname><given-names>JY</given-names></name>
<name><surname>Weintraub</surname><given-names>ES</given-names></name>
<name><surname>Baggs</surname><given-names>JM</given-names></name>
<name><surname>McCarthy</surname><given-names>NL</given-names></name>
<name><surname>Schonberger</surname><given-names>LB</given-names></name>
<name><surname>Lee</surname><given-names>GM</given-names></name>
<etal/>
</person-group>
<article-title>Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006</article-title>
<source>Vaccine</source>
<year>2015</year>
<volume>33</volume>
<fpage>382</fpage>
<lpage>7</lpage>
</element-citation></ref>
<ref id="b68-cep-2022-00150">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Peralta-Amaro</surname><given-names>AL</given-names></name>
<name><surname>Tejada-Ruiz</surname><given-names>MI</given-names></name>
<name><surname>Rivera-Alvarado</surname><given-names>KL</given-names></name>
<name><surname>Cobos-Quevedo</surname><given-names>OJ</given-names></name>
<name><surname>Romero-Hern&#x000e1;ndez</surname><given-names>P</given-names></name>
<name><surname>Mac&#x000ed;as-Arroyo</surname><given-names>W</given-names></name>
<etal/>
</person-group>
<article-title>Atypical Kawasaki disease after COVID-19 vaccination: a new form of adverse event following immunization</article-title>
<source>Vaccines (Basel)</source>
<year>2022</year>
<volume>10</volume>
<fpage>126</fpage>
</element-citation></ref>
<ref id="b69-cep-2022-00150">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jones</surname><given-names>VG</given-names></name>
<name><surname>Mills</surname><given-names>M</given-names></name>
<name><surname>Suarez</surname><given-names>D</given-names></name>
<name><surname>Hogan</surname><given-names>CA</given-names></name>
<name><surname>Yeh</surname><given-names>D</given-names></name>
<name><surname>Segal</surname><given-names>JB</given-names></name>
<etal/>
</person-group>
<article-title>COVID-19 and Kawasaki disease: novel virus and novel case</article-title>
<source>Hosp Pediatr</source>
<year>2020</year>
<volume>10</volume>
<fpage>537</fpage>
<lpage>40</lpage>
</element-citation></ref>
<ref id="b70-cep-2022-00150">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cazzaniga</surname><given-names>M</given-names></name>
<name><surname>Baselli</surname><given-names>LA</given-names></name>
<name><surname>Cimaz</surname><given-names>R</given-names></name>
<name><surname>Guez</surname><given-names>SS</given-names></name>
<name><surname>Pinzani</surname><given-names>R</given-names></name>
<name><surname>Dellepiane</surname><given-names>RM</given-names></name>
</person-group>
<article-title>SARS-COV-2 Infection and Kawasaki disease: case report of a hitherto unrecognized association</article-title>
<source>Front Pediatr</source>
<year>2020</year>
<volume>8</volume>
<fpage>398</fpage>
</element-citation></ref>
<ref id="b71-cep-2022-00150">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Renganathan</surname><given-names>A</given-names></name>
<name><surname>Garg</surname><given-names>A</given-names></name>
<name><surname>Chowdhary</surname><given-names>S</given-names></name>
<name><surname>Raj</surname><given-names>D</given-names></name>
</person-group>
<article-title>SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year-old child</article-title>
<source>BMJ Case Rep</source>
<year>2021</year>
<volume>14</volume>
<elocation-id>e240972</elocation-id>
</element-citation></ref>
<ref id="b72-cep-2022-00150">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Riphagen</surname><given-names>S</given-names></name>
<name><surname>Gomez</surname><given-names>X</given-names></name>
<name><surname>Gonzalez-Martinez</surname><given-names>C</given-names></name>
<name><surname>Wilkinson</surname><given-names>N</given-names></name>
<name><surname>Theocharis</surname><given-names>P</given-names></name>
</person-group>
<article-title>Hyperinflammatory shock in children during COVID-19 pandemic</article-title>
<source>Lancet</source>
<year>2020</year>
<volume>395</volume>
<fpage>1607</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b73-cep-2022-00150">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gkoutzourelas</surname><given-names>A</given-names></name>
<name><surname>Bogdanos</surname><given-names>DP</given-names></name>
<name><surname>Sakkas</surname><given-names>LI</given-names></name>
</person-group>
<article-title>Kawasaki disease and COVID-19</article-title>
<source>Mediterr J Rheumatol</source>
<year>2020</year>
<volume>31</volume>
<issue>Suppl 2</issue>
<fpage>268</fpage>
<lpage>74</lpage>
</element-citation></ref>
<ref id="b74-cep-2022-00150">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sancho-Shimizu</surname><given-names>V</given-names></name>
<name><surname>Brodin</surname><given-names>P</given-names></name>
<name><surname>Cobat</surname><given-names>A</given-names></name>
<name><surname>Biggs</surname><given-names>CM</given-names></name>
<name><surname>Toubiana</surname><given-names>J</given-names></name>
<name><surname>Lucas</surname><given-names>CL</given-names></name>
<etal/>
</person-group>
<article-title>SARS-CoV-2-related MIS-C: a key to the viral and genetic causes of Kawasaki disease?</article-title>
<source>J Exp Med</source>
<year>2021</year>
<volume>218</volume>
<elocation-id>e20210446</elocation-id>
</element-citation></ref>
<ref id="b75-cep-2022-00150">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>L</given-names></name>
<name><surname>Whitaker</surname><given-names>M</given-names></name>
<name><surname>O&#x00027;Halloran</surname><given-names>A</given-names></name>
<name><surname>Kambhampati</surname><given-names>A</given-names></name>
<name><surname>Chai</surname><given-names>SJ</given-names></name>
<name><surname>Reingold</surname><given-names>A</given-names></name>
<etal/>
</person-group>
<article-title>Hospitalization rates and characteristics of children aged &lt;18 years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 states, March 1-July 25, 2020</article-title>
<source>MMWR Morb Mortal Wkly Rep</source>
<year>2020</year>
<volume>69</volume>
<fpage>1081</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b76-cep-2022-00150">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>JK</given-names></name>
<name><surname>Cho</surname><given-names>EY</given-names></name>
<name><surname>Lee</surname><given-names>H</given-names></name>
</person-group>
<article-title>Multisystem inflammatory syndrome in children</article-title>
<source>Pediatr Infect Vaccine</source>
<year>2021</year>
<volume>28</volume>
<fpage>66</fpage>
<lpage>81</lpage>
</element-citation></ref>
<ref id="b77-cep-2022-00150">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Henderson</surname><given-names>LA</given-names></name>
<name><surname>Canna</surname><given-names>SW</given-names></name>
<name><surname>Friedman</surname><given-names>KG</given-names></name>
<name><surname>Gorelik</surname><given-names>M</given-names></name>
<name><surname>Lapidus</surname><given-names>SK</given-names></name>
<name><surname>Bassiri</surname><given-names>H</given-names></name>
<etal/>
</person-group>
<article-title>American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1</article-title>
<source>Arthritis Rheumatol</source>
<year>2020</year>
<volume>72</volume>
<fpage>1791</fpage>
<lpage>805</lpage>
</element-citation></ref>
<ref id="b78-cep-2022-00150">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H</given-names></name>
<name><surname>Shim</surname><given-names>JY</given-names></name>
<name><surname>Ko</surname><given-names>JH</given-names></name>
<name><surname>Yang</surname><given-names>A</given-names></name>
<name><surname>Shim</surname><given-names>JW</given-names></name>
<name><surname>Kim</surname><given-names>DS</given-names></name>
<etal/>
</person-group>
<article-title>Multisystem inflammatory syndrome in children related to COVID-19: the first case in Korea</article-title>
<source>J Korean Med Sci</source>
<year>2020</year>
<volume>35</volume>
<elocation-id>e391</elocation-id>
</element-citation></ref>
<ref id="b79-cep-2022-00150">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kabeerdoss</surname><given-names>J</given-names></name>
<name><surname>Pilania</surname><given-names>RK</given-names></name>
<name><surname>Karkhele</surname><given-names>R</given-names></name>
<name><surname>Kumar</surname><given-names>TS</given-names></name>
<name><surname>Danda</surname><given-names>D</given-names></name>
<name><surname>Singh</surname><given-names>S</given-names></name>
</person-group>
<article-title>Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management</article-title>
<source>Rheumatol Int</source>
<year>2021</year>
<volume>41</volume>
<fpage>19</fpage>
<lpage>32</lpage>
</element-citation></ref>
<ref id="b80-cep-2022-00150">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rhim</surname><given-names>JW</given-names></name>
<name><surname>Kang</surname><given-names>JH</given-names></name>
<name><surname>Lee</surname><given-names>KY</given-names></name>
</person-group>
<article-title>Etiological and pathophysiological enigmas of severe coronavirus disease 2019, multisystem inflammatory syndrome in children and Kawasaki disease</article-title>
<source>Clin Exp Pediatr</source>
<year>2022</year>
<volume>65</volume>
<fpage>153</fpage>
<lpage>66</lpage>
</element-citation></ref>
<ref id="b81-cep-2022-00150">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname><given-names>S</given-names></name>
<name><surname>Chen</surname><given-names>M</given-names></name>
<name><surname>Weng</surname><given-names>J</given-names></name>
</person-group>
<article-title>COVID-19 and Kawasaki disease in children</article-title>
<source>Pharmacol Res</source>
<year>2020</year>
<volume>159</volume>
<fpage>104951</fpage>
</element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures and Tables</title>
<fig id="f1-cep-2022-00150" position="float">
<graphic xlink:href="cep-2022-00150f1.tif"/></fig>
<table-wrap id="t1-cep-2022-00150" position="float">
<label>Table 1.</label>
<caption><p>Evidence of connection between Kawasaki disease and infection</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Feature</th>
<th align="center" valign="middle">Evidences related to infection</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="6">Clinical</td>
<td valign="top" align="left">Acute fever</td>
</tr>
<tr>
<td valign="top" align="left">Skin rash</td>
</tr>
<tr>
<td valign="top" align="left">Conjunctival injection</td>
</tr>
<tr>
<td valign="top" align="left">Diffuse oral mucositis</td>
</tr>
<tr>
<td valign="top" align="left">Lymphadenitis</td>
</tr>
<tr>
<td valign="top" align="left">Accompanying respiratory symptoms</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="5">Epidemiological</td>
<td valign="top" align="left">Age distribution: common in young children aged &lt;5 years</td>
</tr>
<tr>
<td valign="top" align="left">Family clustering</td>
</tr>
<tr>
<td valign="top" align="left">Geographic clustering</td>
</tr>
<tr>
<td valign="top" align="left">Marked seasonality</td>
</tr>
<tr>
<td valign="top" align="left">Antecedent infection outbreak prior to Kawasaki disease</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Pathological</td>
<td valign="top" align="left">Explosive systemic vasculitis suspicious of the connection with microbial toxin and superantigen</td>
</tr>
<tr>
<td valign="top" align="left">Self-limited</td>
</tr>
<tr>
<td valign="top" align="left">Immunological</td>
<td valign="top" align="left">Intracytoplasmic inclusion bodies in Kawasaki disease tissues</td>
</tr>
</tbody></table>
</table-wrap>

<table-wrap id="t2-cep-2022-00150" position="float">
<label>Table 2.</label>
<caption><p>Major pathogens reported as related to Kawasaki disease infection</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Types</th>
<th align="center" valign="middle" colspan="2">Pathogens</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Bacteria</td>
<td valign="top" align="left" colspan="2"><italic>Staphylococcus aureus, Group A Streptococcus, Streptococcus pyogenes, Yersinia pseudotuberculosis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Chlamydiae pneumoniae, Mycoplasma pneumoniae, Rickettial organisms</italic></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">Viruses</td>
<td valign="top" align="left">DNA viruses</td>
<td valign="top" align="left">Adenovirus, Epstein-Barr virus, Human parvovirus B19, Herpesvirus 6, Varicella-zoster virus, Human bocavirus, Torque teno virus</td>
</tr>
<tr>
<td valign="top" align="left">RNA viruses</td>
<td valign="top" align="left">Rotavirus, Enterovirus, Dengue virus, Parainfluenza type 3 virus, Human coronavirus NL63/OC43/229E/HKU1, Human metapneumovirus, Measles virus, Influenza A (H1N1), Severe respiratory syndrome coronavirus 2 (COVID-19)</td>
</tr>
<tr>
<td valign="top" align="left">Reverse transcribing viruses</td>
<td valign="top" align="left">Human immunodeficiency virus</td>
</tr>
<tr>
<td valign="top" align="left">Fungi</td>
<td valign="top" align="left" colspan="2">Candida species, Candida albicans</td>
</tr>
</tbody></table>
</table-wrap>

<table-wrap id="t3-cep-2022-00150" position="float">
<label>Table 3.</label>
<caption><p>Summary of characteristics of studies of bacteria as Kawasaki disease-related pathogens</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Study</th>
<th align="center" valign="middle">Pathogens</th>
<th align="center" valign="middle">Study details</th>
<th align="center" valign="middle">Results/conclusions</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="2">Leung et al. [<xref ref-type="bibr" rid="b20-cep-2022-00150">20</xref>] (1993)</td>
<td valign="top" align="left"><italic>Staphylococcus aureus</italic></td>
<td valign="top" align="left">Control study</td>
<td valign="top" align="left" rowspan="2">Selective expansion of V&#x003B2;2 + T cells in most patients with KD may be caused by a toxic shock syndrome toxinproducing <italic>S. aureus</italic>, and in a minority of patients, SPEBproducing or SPEC-producing streptococci.</td>
</tr>
<tr>
<td valign="top" align="left"><italic>Streptococcus pyogenes</italic></td>
<td valign="top" align="left">16 Acute KD patients &amp; 15 controls</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="5">Matsubara and Fukaya [<xref ref-type="bibr" rid="b22-cep-2022-00150">22</xref>] (2007)</td>
<td valign="top" align="left">Group A <italic>Streptococcus</italic></td>
<td valign="top" align="left">Review recent publications</td>
<td valign="top" align="left">Evidences support the involvement of superantigens in the pathogenesis of KD:</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="4"><italic>Staphylococcus aureus</italic></td>
<td valign="top" align="left" rowspan="4">Total number of known staphylococcal superantigens to over 20 and streptococcal superantigens to 12</td>
<td valign="top" align="left">- the skewed distribution of the V&#x003B2; repertoire;</td>
</tr>
<tr>
<td valign="top" align="left">- superantigen-producing bacteria has been isolated from KD patients;</td>
</tr>
<tr>
<td valign="top" align="left">- the serological responses to superantigens produced by <italic>S. aureus</italic> and GAS from case-control studies; and</td>
</tr>
<tr>
<td valign="top" align="left">- animal models have demonstrated all the hallmarks of a superantigen-mediated response.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">Konishi et al. [<xref ref-type="bibr" rid="b24-cep-2022-00150">24</xref>] (1997)</td>
<td valign="top" align="left" rowspan="3"><italic>Yersinia pseudotuberculosis</italic></td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="3"><italic>Y. pseudotuberculosis</italic> might be closely related to the cause of KD.</td>
</tr>
<tr>
<td valign="top" align="left">5-year-old boy, KD with CAL</td>
</tr>
<tr>
<td valign="top" align="left">Mitogenic activity by culture and PCR</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Keren et al. [<xref ref-type="bibr" rid="b26-cep-2022-00150">26</xref>] (1983)</td>
<td valign="top" align="left" rowspan="2"><italic>Pseudomonas aeruginosa</italic></td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="2">Pseudomonas infection appeared to be the underlying cause of both the clinical symptoms and the pathological changes of Kawasaki disease.</td>
</tr>
<tr>
<td valign="top" align="left">Clinical, laboratory and histopathological findings of 13 patients with KD</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">Normann et al. [<xref ref-type="bibr" rid="b27-cep-2022-00150">27</xref>] (1999)</td>
<td valign="top" align="left" rowspan="3"><italic>Chlamydiae pneumoniae</italic></td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="3">First report about the demonstration of <italic>C. pneumoniae</italic> in cardiovascular tissues from children with KD</td>
</tr>
<tr>
<td valign="top" align="left">8-year-old boy</td>
</tr>
<tr>
<td valign="top" align="left">Immunohistochemical study for tissue</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Tang et al. [<xref ref-type="bibr" rid="b28-cep-2022-00150">28</xref>] (2016)</td>
<td valign="top" align="left" rowspan="2"><italic>Mycoplasma pneumoniae</italic></td>
<td valign="top" align="left">Prospectively analysis of clinical records</td>
<td valign="top" align="left" rowspan="2">MP infections are found in an important proportion of the KD patients (13.8 % in our series).</td>
</tr>
<tr>
<td valign="top" align="left">450 Patients with KD (2012&#x02013;2014)</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>KD, Kawasaki disease; SPEB, streptococcal pyogenic exotoxin B; SPEC, streptococcal pyogenic exotoxin C; GAS, group A Streptococcus; CAL, coronary artery lesion; PCR, polymerase chain reaction; MP, <italic>Mycoplasma pneumoniae</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>

<table-wrap id="t4-cep-2022-00150" position="float">
<label>Table 4.</label>
<caption><p>Summary of the characteristics of studies of viruses as Kawasaki disease-related pathogens</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Study</th>
<th align="center" valign="middle">Viruses</th>
<th align="center" valign="middle">Study details</th>
<th align="center" valign="middle">Results/conclusions</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="4">Okano et al. [<xref ref-type="bibr" rid="b30-cep-2022-00150">30</xref>] (1990)</td>
<td valign="top" align="left">Adenovirus</td>
<td valign="top" align="left">Retrospective study</td>
<td valign="top" align="left" rowspan="2">Two of 12 (16.7%) in 1982 and 1 of 10 (10.0%) in 1985 showed positive antibodies for the common adenovirus antigen by CF test. By ELISA test, 9 of 12 (75.0%) in 1982 and 9 of 10 (90.0%) in 1985 had antibodies to adenovirus type 2.</td>
</tr>
<tr>
<td valign="top" align="left">Herpes simplex virus type 1 &amp; 2 (HSV-1 &amp; HSV-2)</td>
<td valign="top" align="left" rowspan="3">Two outbreaks of KD at different times and areas (12 patients Kyoto in 1982 and 10 Sapporo in 1985), Antibody detection by CF and ELISA</td>
</tr>
<tr>
<td valign="top" align="left">Varicella-zoster virus (VZV)</td>
<td valign="top" align="left" rowspan="2">No significant difference HSV-1 and HSV-2, VZV, and CMV between patients and controls</td>
</tr>
<tr>
<td valign="top" align="left">Cytomegalovirus (CMV)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">Rosenfeld et al. [<xref ref-type="bibr" rid="b31-cep-2022-00150">31</xref>] (2020)</td>
<td valign="top" align="left" rowspan="3">Epstein-Barr virus (EBV)</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="3">Concomitant EBV infection was supported by positive serology for acute EBV infection (positive IgM VCA EBV antibodies).</td>
</tr>
<tr>
<td valign="top" align="left">19-month-old boy</td>
</tr>
<tr>
<td valign="top" align="left">KD with a concomitant primary EBV infection</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Holm et al. [<xref ref-type="bibr" rid="b33-cep-2022-00150">33</xref>] (1995)</td>
<td valign="top" align="left" rowspan="2">Parvovirus B19</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="2">Serologically diagnosed parvovirus B19 infection in KD patients supports the hypothesis of an etiological relationship between parvovirus B19 infection and KD.</td>
</tr>
<tr>
<td valign="top" align="left">9-week-old boy</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Okano et al. [<xref ref-type="bibr" rid="b34-cep-2022-00150">34</xref>] (1989)</td>
<td valign="top" align="left" rowspan="2">Human herpesvirus 6</td>
<td valign="top" align="left">Case-control study</td>
<td valign="top" align="left">Eighteen of 22 (81.8%) with KD were positive for immunoglobulin G or M antibodies to human herpesvirus 6, whereas 10 of 16 age- and sex-matched healthy controls (62.5%) were seropositive.</td>
</tr>
<tr>
<td valign="top" align="left">22 patients with KD, and 16 age- and sexmatched healthy controls</td>
<td valign="top" align="left">Human herpesvirus 6 infection may be a reflection of the immunologic alterations that are associated with KD.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Matsuno et al. [<xref ref-type="bibr" rid="b36-cep-2022-00150">36</xref>] (1983)</td>
<td valign="top" align="left" rowspan="2">Rotavirus</td>
<td valign="top" align="left">Case-control study</td>
<td valign="top" align="left" rowspan="2">A significant increase in antibody to rotavirus was 38 cases (50.7%) in KD, otherwise 3 cases(7.8%) in controls.</td>
</tr>
<tr>
<td valign="top" align="left">Serology test for 75 patients with KD and 39 age-matched healthy controls</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">Singh et al. [<xref ref-type="bibr" rid="b38-cep-2022-00150">38</xref>] (2009)</td>
<td valign="top" align="left" rowspan="3">Dengue virus</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="3">A child presenting with fever and rash, can have more than one underlying condition.</td>
</tr>
<tr>
<td valign="top" align="left">8-year-old boy</td>
</tr>
<tr>
<td valign="top" align="left">Dengue IgM antibody(+), developed findings consistent with KD</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Lee et al. [<xref ref-type="bibr" rid="b39-cep-2022-00150">39</xref>] (2004)</td>
<td valign="top" align="left" rowspan="2">Varicella-zoster virus</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left">Two sisters showed a characteristic feature of KD immediately after a primary infection by VZV.</td>
</tr>
<tr>
<td valign="top" align="left">4-year-old &amp; 5-year-old (sisters)</td>
<td valign="top" align="left">VZV infection may cause severe complication and may be associated with KD.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Belostotsky et al. [<xref ref-type="bibr" rid="b40-cep-2022-00150">40</xref>] (2004)</td>
<td valign="top" align="left" rowspan="2">Human immunodeficiency virus (HIV)</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="2">Atypical KD with coronary artery aneurysm formation in an HIV-infected adolescent suggests that KD may occur in patients with immunodeficiency.</td>
</tr>
<tr>
<td valign="top" align="left">14-year-old boy with advanced perinatal HIV infection</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Shirato et al. [<xref ref-type="bibr" rid="b41-cep-2022-00150">41</xref>] (2014)</td>
<td valign="top" align="left" rowspan="2">Human corona virus (HCoV)-NL63, HCoV-229E</td>
<td valign="top" align="left">Case-control study</td>
<td valign="top" align="left" rowspan="2">Serological tests did not support the involvement of HCoVNL63 but suggested the possible involvement of HCoV-229E in the development of KD.</td>
</tr>
<tr>
<td valign="top" align="left">15 Patients with KD and 23 controls &amp; 29 controls, by IF assays and virus neutralizing tests</td>
</tr>
<tr>
<td valign="top" align="left">Catalano-Pons et al. [<xref ref-type="bibr" rid="b42-cep-2022-00150">42</xref>] (2007)</td>
<td valign="top" align="left">Human bocavirus (HBoV)</td>
<td valign="top" align="left">Nasopharyngeal, serum or stool samples from 16 patients with KD by PCR</td>
<td valign="top" align="left">HBoV was identified in 5 patients (31.2%) by PCR, suggesting that this virus may also play a pathogenic role in some cases of KD.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Giray et al. [<xref ref-type="bibr" rid="b43-cep-2022-00150">43</xref>] (2016)</td>
<td valign="top" align="left" rowspan="2">Adenovirus, HCoV-OC43/HKU1, Parainfluenza virus type 3</td>
<td valign="top" align="left" rowspan="2">4 cases report</td>
<td valign="top" align="left">Adenovirus in 4-year-old boy &amp; 3-year-old boy, HCoV-OC43/HKU1 in 17-month-old girl</td>
</tr>
<tr>
<td valign="top" align="left">Parainfluenza virus type 3 in 4-year-old girl</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Song et al. [<xref ref-type="bibr" rid="b44-cep-2022-00150">44</xref>] (2016)</td>
<td valign="top" align="left" rowspan="2">Adenovirus</td>
<td valign="top" align="left">Comparative study</td>
<td valign="top" align="left" rowspan="2">Twenty-four of 25 children with adenovirus disease and mimicking features of KD had &lt;4 KD-like features</td>
</tr>
<tr>
<td valign="top" align="left">31 Patients with KD</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Thissen et al. [<xref ref-type="bibr" rid="b45-cep-2022-00150">45</xref>] (2018)</td>
<td valign="top" align="left" rowspan="2">Torque teno virus(TTV) 7</td>
<td valign="top" align="left">Case-control study</td>
<td valign="top" align="left" rowspan="2">Sanger sequencing revealed that the TTV 7 found in the 2 KD patients contained almost identical variants in nucleotide and identical changes in resulting amino acid, relative to the reference sequence</td>
</tr>
<tr>
<td valign="top" align="left">11 Patients with KD and 22 controls</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Wang et al. [<xref ref-type="bibr" rid="b46-cep-2022-00150">46</xref>] (2019)</td>
<td valign="top" align="left" rowspan="2">Influenza A (H1N1) pdm09</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="2">More attention should be paid to the correlation between KD and pathogen infection, especially the new influenza virus H1N1.</td>
</tr>
<tr>
<td valign="top" align="left">19-month-old boy</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Choe et al. [<xref ref-type="bibr" rid="b47-cep-2022-00150">47</xref>] (2020)</td>
<td valign="top" align="left" rowspan="2">HCoV</td>
<td valign="top" align="left">Big data analysis(2016&#x02013;2019)</td>
<td valign="top" align="left" rowspan="2">Cumulative association of KD per 10% increase of HCoV over 1 month&#x02010;lag was 0.50 (95% CI, 0.16&#x02013;1.53), suggesting that seasonal variation in the frequencies of HCoV was not significantly associated with the incidence of KD.</td>
</tr>
<tr>
<td valign="top" align="left">Using national representable data from sentinel surveillance and the Health Insurance Review &amp; Assessment Service</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Quiat et al. [<xref ref-type="bibr" rid="b51-cep-2022-00150">51</xref>] (2020)</td>
<td valign="top" align="left" rowspan="2">58 viruses</td>
<td valign="top" align="left">Detection of antiviral antibodies in KD patients and matched controls.</td>
<td valign="top" align="left">No differences in antiviral antibody profiles.</td>
</tr>
<tr>
<td valign="top" align="left">Comprehensive serological profiling using a high-throughput PhIP-seq. assay</td>
<td valign="top" align="left">In the acute and subacute phases of disease, there is no serological evidence that KD patients are exposed to known viruses than controls.</td>
</tr>
<tr>
<td valign="top" align="left">Aguirre et al. [<xref ref-type="bibr" rid="b52-cep-2022-00150">52</xref>] (2021)</td>
<td valign="top" align="left">Respiratory syncytial virus (RSV), Influenza A &amp; B virus, Metapneumovirus</td>
<td valign="top" align="left">Ecologic study of respiratory viruses in Chile, between 2010&#x02013;2017.</td>
<td valign="top" align="left">There is a direct temporal correlation between RSV, influenza A, influenza B, and metapneumovirus circulation and KD.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">Farahmand et al. [<xref ref-type="bibr" rid="b60-cep-2022-00150">60</xref>] (2021)</td>
<td valign="top" align="left">Human parvovirus B19</td>
<td valign="top" align="left">Meta-analysis</td>
<td valign="top" align="left" rowspan="3">Human parvovirus B19, EBV, human herpesvirus-6 are highly suspected to be key contributors to the development of KD.</td>
</tr>
<tr>
<td valign="top" align="left">EBV</td>
<td valign="top" align="left" rowspan="2">Search for relevant studies (1984&#x02013;2019)</td>
</tr>
<tr>
<td valign="top" align="left">Human herpesvirus-6</td>
</tr>
<tr>
<td valign="top" align="left">Lim et al. [<xref ref-type="bibr" rid="b17-cep-2022-00150">17</xref>] (2021)</td>
<td valign="top" align="left">11 Respiratory viruses</td>
<td valign="top" align="left">National data from Health Insurance Review and Assessment in Korea by Granger test</td>
<td valign="top" align="left">Positive detection rate for RSV, rotavirus, rhinovirus and norovirus were related with KD incidence by 1 or 2 months.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Kang et al. [<xref ref-type="bibr" rid="b18-cep-2022-00150">18</xref>] (2022)</td>
<td valign="top" align="left" rowspan="2">14 Respiratory viruses</td>
<td valign="top" align="left">Cohort study for 53,424 with KD</td>
<td valign="top" align="left" rowspan="2">Respiratory infections caused by rhinovirus and RSV and varicella outbreaks were significantly correlated with KD at 1 to 3 months before KD outbreaks.</td>
</tr>
<tr>
<td valign="top" align="left">National data from Korean National Health Insurance Service(Dec. 2020&#x02013;Oct. 2021)</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>KD, Kawasaki disease; CF, complement fixation; ELISA, enzyme-linked immunosorbent assay; VCA, viral capsid antigen; IF, immunofluorescence; PhIP-seq, phage immunoprecipitation sequencing; PCR, polymerase chain reaction.</p></fn>
</table-wrap-foot>
</table-wrap>

<table-wrap id="t5-cep-2022-00150" position="float">
<label>Table 5.</label>
<caption><p>Summary of studies of vaccinations as triggering factors of Kawasaki disease</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Study</th>
<th align="center" valign="middle">Vaccines</th>
<th align="center" valign="middle">Study details</th>
<th align="center" valign="middle">Results/conclusions</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="2">Miron et al. [<xref ref-type="bibr" rid="b62-cep-2022-00150">62</xref>] (2003)</td>
<td valign="top" align="left" rowspan="2">Hapatitis B</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left">KD occurred 1 day after receiving second dose of hepatitis B vaccine.</td>
</tr>
<tr>
<td valign="top" align="left">35-day-old infant</td>
<td valign="top" align="left">When there is a strong temporal relationship between HBV and KD, it should be considered to withhold additional doses of hepatitis B vaccine.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Yin et al. [<xref ref-type="bibr" rid="b63-cep-2022-00150">63</xref>] (2015)</td>
<td valign="top" align="left" rowspan="2">Rotavirus &amp; hepatitis A</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="2">KD after second dose of Lanzhou lamb rotavirus vaccine and first dose of freeze-dried live attenuated hepatitis A vaccine</td>
</tr>
<tr>
<td valign="top" align="left">20-month-old girl</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Shimada et al. [<xref ref-type="bibr" rid="b64-cep-2022-00150">64</xref>] (2015)</td>
<td valign="top" align="left" rowspan="2">Influenza</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="2">Although the mechanism underlying the development of influenza vaccine-induced vasculitides is unknown, a possible link between influenza vaccination and autoimmunity has been suggested, and influenza vaccination possibly served as a trigger for the development of KD.</td>
</tr>
<tr>
<td valign="top" align="left">2-year-old girl, received 2 doses of the influenza vaccine 36 and 8 days before the onset of KD</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Bonetto et al. [<xref ref-type="bibr" rid="b65-cep-2022-00150">65</xref>] (2016)</td>
<td valign="top" align="left" rowspan="2">Influenza, HBV, BCG, HPV, MGC, HAV, Rotavirus, DPT, Typhoid fever, MMR, Yellow fever, Anthrax, Pandemic influenza</td>
<td valign="top" align="left">Review</td>
<td valign="top" align="left" rowspan="2">Vasculitis were more frequently reported in association with influenza vaccines.</td>
</tr>
<tr>
<td valign="top" align="left">75 Articles from 1st January 1994 to 30th June 2014</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Hua et al. [<xref ref-type="bibr" rid="b66-cep-2022-00150">66</xref>] (2009)</td>
<td valign="top" align="left" rowspan="2">RotaTeq &amp; 22 types of FDA licensed vaccines</td>
<td valign="top" align="left">Case analysis</td>
<td valign="top" align="left" rowspan="2">Does not suggest an elevated KD risk for RotaTeq or other vaccines.</td>
</tr>
<tr>
<td valign="top" align="left">107 KD in total of 239,535 reports by vaccine adverse event reporting system for all US licensed vaccines since 1990 to 2007</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Abrams et al. [<xref ref-type="bibr" rid="b67-cep-2022-00150">67</xref>] (2015)</td>
<td valign="top" align="left" rowspan="2">Varicella, Influenza, Pertussis, Mumps, Pneumococcus, Hepatitis A or B, Haemophilus influenzae type b, Measles, Tetanus, Rubella, Diphtheria, Polio</td>
<td valign="top" align="left">Longitudinal, multi-site study on 1.7 million children for 4.4 million person-years.</td>
<td valign="top" align="left">Observed decreased rate of KD during 42 days after vaccination.</td>
</tr>
<tr>
<td valign="top" align="left">Data from the Vaccine Safety Datalink were collected from 7 managed care organizations across the United States for children aged 0&#x02013;6 years (1996&#x02013;2006).</td>
<td valign="top" align="left">No evidence for increased rate of Kawasaki disease following vaccination. Findings provide strong evidence that vaccines are not a cause of Kawasaki disease.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Peralta-Amaro et al. [<xref ref-type="bibr" rid="b68-cep-2022-00150">68</xref>] (2022)</td>
<td valign="top" align="left" rowspan="2">COVID-19 (nonreplicable viral vector Vaxzevria)</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="2">Symptoms begin 22 days after the application first dose of the COVID-19 vaccine This is the first case described of atypical KD after COVID-19 vaccination.</td>
</tr>
<tr>
<td valign="top" align="left">18-year-old man</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>KD, Kawasaki disease; HBV, hepatitis B vaccination; BCG, Bacille Calmette-Guerin; HPV, human papillomavirus vaccination; MGC, meningococcal vaccination; HAV, hepatitis A vaccination; DPT, diphtheria, pertussis, and tetanus vaccination; MMR, measles, mumps, and rubella vaccination; FDA, U.S. Food and Drug Association; RotaTeq, rotavirus live vaccine; COVID-19, coronavirus disease-2019.</p></fn>
</table-wrap-foot>
</table-wrap>

<table-wrap id="t6-cep-2022-00150" position="float">
<label>Table 6.</label>
<caption><p>Comparison of multisystem inflammatory syndrome in children (MIS-C), severe COVID-19 disease without MIS-C, toxic shock syndrome (TSS), and Kawasaki disease (KD)</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle" colspan="2">Characteristics</th>
<th align="center" valign="middle">MIS-C</th>
<th align="center" valign="middle">Severe COVID-19 without MIS-C</th>
<th align="center" valign="middle">TSS</th>
<th align="center" valign="middle">KD</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="2">Age</td>
<td valign="top" align="left">8&#x02013;10 Years</td>
<td valign="top" align="left">Adolescents</td>
<td valign="top" align="left">&gt;10 Years</td>
<td valign="top" align="left">&lt;5 Years</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2">Sex</td>
<td valign="top" align="left">Male &gt; female</td>
<td valign="top" align="left">Male = female</td>
<td valign="top" align="left">Male &lt; female</td>
<td valign="top" align="left">Male &gt; female</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2" colspan="2">Etiology</td>
<td valign="top" align="left">Suspected by SARS-CoV-2</td>
<td valign="top" align="left" rowspan="2">SARS-CoV-2</td>
<td valign="top" align="left" rowspan="2">Focus of staphylococcal or streptococcal infection</td>
<td valign="top" align="left" rowspan="2">No definite identifiable cause</td>
</tr>
<tr>
<td valign="top" align="left">History of contact with an individual having COVID-19 infection in cases of seronegative patients</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2">Clinical manifestations</td>
<td valign="top" align="left"></td>
<td valign="top" align="left"></td>
<td valign="top" align="left"></td>
<td valign="top" align="left"></td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;</td>
<td valign="top" align="left">Fever</td>
<td valign="top" align="left">Present</td>
<td valign="top" align="left">Present</td>
<td valign="top" align="left">Present</td>
<td valign="top" align="left">Present</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Cutaneous signs</td>
<td valign="top" align="left">Similar to KD</td>
<td valign="top" align="left">Usually absent</td>
<td valign="top" align="left">Erythroderma and petechiae</td>
<td valign="top" align="left">Typical signs</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Lymphadenopathy</td>
<td valign="top" align="left">Not common</td>
<td valign="top" align="left">Not known</td>
<td valign="top" align="left">Less common</td>
<td valign="top" align="left">More common</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Hemodynamic instability</td>
<td valign="top" align="left">Almost all</td>
<td valign="top" align="left">In case of multiorgan dysfunction</td>
<td valign="top" align="left">Usually present</td>
<td valign="top" align="left">Less than 5%</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left"></td>
<td valign="top" align="left"></td>
<td valign="top" align="left"></td>
<td valign="top" align="left"></td>
<td valign="top" align="left"></td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Cardiac complications</td>
<td valign="top" align="left">Myocarditis, pericarditis</td>
<td valign="top" align="left">Usually not seen</td>
<td valign="top" align="left">Myocardial dysfunction</td>
<td valign="top" align="left">CAL/Aneurysm</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Gastrointestinal symptoms</td>
<td valign="top" align="left">Prominent (&gt;80%)</td>
<td valign="top" align="left">Less common</td>
<td valign="top" align="left">Not common</td>
<td valign="top" align="left">Not common</td>
</tr>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="left">Organ dysfunction</td>
<td valign="top" align="left">Multiorgan dysfunction</td>
<td valign="top" align="left">ARDS, MAS, shock are common</td>
<td valign="top" align="left">Renal and central nervous system</td>
<td valign="top" align="left">Not common</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2">Laboratory findings Anti-HCoV antibodies</td>
<td valign="top" align="left">Lymphopenia, cytokine storm 70%&#x02013;90%</td>
<td valign="top" align="left">Lymphopenia, neutropenia Nearly 90%</td>
<td valign="top" align="left">Neutrophilic leukocytosis No data</td>
<td valign="top" align="left">Neutrophilic leukocytosis Lack of data</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2">Management</td>
<td valign="top" align="left">IVIG, steroids, IL-1 blockers, IL-6 inhibitors</td>
<td valign="top" align="left">Antiviral agents, antibiotics, IVIG, steroids, IL-6 inhibitors</td>
<td valign="top" align="left">Antibiotics, IVIG</td>
<td valign="top" align="left">IVIG, steroid, IL-1 blockers</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>COVID-19, coronavirus disease-2019; SARS-CoV-2 Severe acute respiratory syndrome coronavirus-2; ARDS, acute respiratory distress syndrome; MAS, macrophage activation syndrome; CAL, coronary artery lesion; IVIG intravenous immunoglobulin; IL, interleukin.</p>
<p>Modified from Kabeerdoss et al. Rheumatol Int 2021;41;19-32. [<xref ref-type="bibr" rid="b79-cep-2022-00150">79</xref>]</p></fn>
</table-wrap-foot>
</table-wrap>

<table-wrap id="t7-cep-2022-00150" position="float">
<label>Table 7.</label>
<caption><p>Summary of studies of SARS-CoV-2 infection and Kawasaki disease</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Study</th>
<th align="center" valign="middle">Study details</th>
<th align="center" valign="middle">Results/conclusions</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="2">Jones et al. [<xref ref-type="bibr" rid="b69-cep-2022-00150">69</xref>] (2020)</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left">He also screened positive for COVID-19 in the setting of fever and minimal respiratory symptoms.</td>
</tr>
<tr>
<td valign="top" align="left">6-month-old infant with a classic KD</td>
<td valign="top" align="left">The patient was treated per treatment guidelines, with IVIG and high-dose aspirin, and subsequently resolution of clinical symptoms without CAL.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Cazzaniga et al. [<xref ref-type="bibr" rid="b70-cep-2022-00150">70</xref>] (2020)</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="2">PCR tests showed that this patient was infected by enterovirus, rhinovirus, and SARS-COV-2. It is difficult to understand which of the 3 viral agents had been the trigger.</td>
</tr>
<tr>
<td valign="top" align="left">6-year-old boy with a complete form of KD</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Renganathan et al. [<xref ref-type="bibr" rid="b71-cep-2022-00150">71</xref>] (2021)</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="2">SARS-CoV-2 infection triggered the recurrence of KD in children who might have been genetically predisposed to KD.</td>
</tr>
<tr>
<td valign="top" align="left">10-year-old boy, who had previously developed KD at 4 years of age</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Riphagen et al. [<xref ref-type="bibr" rid="b72-cep-2022-00150">72</xref>] (2020)</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left" rowspan="2">This clinical picture represents a new phenomenon affecting previously asymptomatic children with SARS-CoV-2 infection manifesting as a hyperinflammatory syndrome with multiorgan involvement similar to Kawasaki disease shock syndrome</td>
</tr>
<tr>
<td valign="top" align="left">Unprecedented cluster of 8 children with hyperinflammatory shock, showing features similar to atypical Kawasaki disease, KD shock syndrome</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Gkoutzourelas et al. [<xref ref-type="bibr" rid="b73-cep-2022-00150">73</xref>] (2020)</td>
<td valign="top" align="left">Review</td>
<td valign="top" align="left" rowspan="2">MIS-C related to the SARS-CoV-2 pandemic (also termed Kawasaki-like disease, or Kawa-COVID-19) appears to share clinical, pathogenetic and laboratory features with KD, toxic shock syndrome, and MAS.</td>
</tr>
<tr>
<td valign="top" align="left">KD and COVID-19.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Sancho-Shimizu et al. [<xref ref-type="bibr" rid="b74-cep-2022-00150">74</xref>] (2021)</td>
<td valign="top" align="left">Review</td>
<td valign="top" align="left">SARS-CoV-2 is the trigger for MIS-C, which typically occurs about 1 month after infection</td>
</tr>
<tr>
<td valign="top" align="left">SARS-CoV-2 related MIS-C</td>
<td valign="top" align="left">Suggest that rare inborn errors of immunity altering the immune response to SARS-CoV-2 may underlie the pathogenesis of MIS-C in some children</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Verdoni et al. [<xref ref-type="bibr" rid="b3-cep-2022-00150">3</xref>] (2020)</td>
<td valign="top" align="left">Observational cohort study</td>
<td valign="top" align="left">Thirty-fold increased incidence of Kawasaki-like disease: 19 patients in group 1, 10 patients in group 2.</td>
</tr>
<tr>
<td valign="top" align="left">Kawasaki-like disease incidence: before(group 1, 5 years) or after (group 2, 2 months) SARS-CoV-2 epidemic</td>
<td valign="top" align="left">SARS-CoV-2 epidemic was associated with high incidence of a severe form of Kawasaki disease</td>
</tr>
<tr>
<td valign="top" align="left">Kang et al. [<xref ref-type="bibr" rid="b4-cep-2022-00150">4</xref>] (2021)</td>
<td valign="top" align="left">Retrospective ecologic study</td>
<td valign="top" align="left">KD incidence decreased significantly after the implementation of nonpharmacological interventions in Korea</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Ae et al. [<xref ref-type="bibr" rid="b5-cep-2022-00150">5</xref>] (2021)</td>
<td valign="top" align="left">Epidemiologic study</td>
<td valign="top" align="left" rowspan="2">During the social distancing period in 2020, KD was approximately 35% lower than in 2017-2019. The weekly reduction in patient numbers differed between KD and PIDs during 2020, with no strong correlation between the 2 diseases. However, these findings indicate the possibility that triggering KD might be associated with unidentified respiratory pathogens.</td>
</tr>
<tr>
<td valign="top" align="left">Association between KD and common pediatric infectious diseases (PIDs) during COVID-19</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Yang and Kuo[<xref ref-type="bibr" rid="b6-cep-2022-00150">6</xref>] (2021)</td>
<td valign="top" align="left">Retrospective case series study</td>
<td valign="top" align="left" rowspan="2">Compared with the 2018 and 2019 databases, KD incidence decreased significantly by 30% and 31%, respectively (<italic>P</italic>&lt;0.05) in 2020, when public health interventions were comprehensively implemented in Taiwan. Is KD a preventable disease?</td>
</tr>
<tr>
<td valign="top" align="left">Patients with KD between 2018 and 2020 were included for trend analysis</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Kim et al. [<xref ref-type="bibr" rid="b79-cep-2022-00150">79</xref>] (2020)</td>
<td valign="top" align="left">Case report</td>
<td valign="top" align="left">The first case in Korea</td>
</tr>
<tr>
<td valign="top" align="left">11-year-old boy with MIS-C related COVID-19</td>
<td valign="top" align="left">The child fully recovered after treatment corresponding to KDSS.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Kabeerdoss et al. [<xref ref-type="bibr" rid="b79-cep-2022-00150">79</xref>] (2021)</td>
<td valign="top" align="left">Review</td>
<td valign="top" align="left" rowspan="2">Clinical manifestations of MIS-C mimic KD shock syndrome. MIS-C develops 4-6 weeks following SARS-CoV-2 infection, and is presumably initiated by adaptive immune response.</td>
</tr>
<tr>
<td valign="top" align="left">MIS-C caused by SARS-CoV-2</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Rhim et al. [<xref ref-type="bibr" rid="b80-cep-2022-00150">80</xref>] (2022)</td>
<td valign="top" align="left">Review</td>
<td valign="top" align="left" rowspan="2">Immunopathogenesis is similar among these diseases and suggests that the host's common regulatory system may act for each insult</td>
</tr>
<tr>
<td valign="top" align="left">Severe COVID-19, KD, and MIS-C</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Xu et al. [<xref ref-type="bibr" rid="b81-cep-2022-00150">81</xref>] (2020)</td>
<td valign="top" align="left">Comment</td>
<td valign="top" align="left" rowspan="2">SARS-CoV-2 infection and hyperinflammation in COVID-19 could be acting as the "priming trigger" that could lead to KD</td>
</tr>
<tr>
<td valign="top" align="left">Potential link between COVID-19 and KD</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; KD, Kawasaki disease; COVID-19, coronavirus disease 2019; IVIG intravenous immunoglobulin; CAL, coronary artery lesion; MIS-C, multisystem inflammatory syndrome in children; MAS, macrophage activation syndrome; KDSS, Kawasaki disease shock syndrome.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</back></article>